clomipramine has been researched along with Depression, Endogenous in 383 studies
Clomipramine: A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine.
clomipramine : A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We examined the effects of long-term (six months) treatment with the serotonin potentiating tricyclic antidepressant clomipramine on several serotonergic parameters in panic disorder and depressive patients." | 9.08 | Effects of clomipramine on plasma amino acids and serotonergic parameters in panic disorder and depression. ( Fekkes, D; Pepplinkhuizen, L; Timmerman, L, 1997) |
| "There have been many attempts to find predictors of the therapeutic response to the clomipramine treatment of obsessive-compulsive disorder." | 9.07 | Predictors of treatment response in obsessive-compulsive disorder: multivariate analyses from a multicenter trial of clomipramine. ( Ackerman, DL; Bystritsky, A; Greenland, S; Katz, RJ; Morgenstern, H, 1994) |
| "A double-blind clinical trial of clomipramine versus phenelzine was carried out on 30 patients suffering from DSM-III obsessive-compulsive disorder." | 9.07 | Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial. ( Bulbena, A; Marcos, T; Menchón, JM; Olivares, J; Vallejo, J, 1992) |
| "Seventeen outpatients with panic anxiety and agoraphobia were treated with a low, flexible dose of clomipramine in an 8-week open trial." | 9.06 | Panic attacks and agoraphobia: low dose clomipramine treatment. ( Codner, S; Cohen, L; Gladic, D; Gloger, S; Grunhaus, L; O'Ryan, F, 1989) |
| "The effect of clomipramine hydrochloride in severe obsessive-compulsive disorder (OCD) was compared with that of nortriptyline hydrochloride and placebo in a five-week randomized, double-blind trial." | 9.05 | Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial. ( Asberg, M; Cronholm, B; Jörnestedt, L; Thorén, P; Träskman, L, 1980) |
| "In this retrospective analysis, we analyzed all clinical record data in our Medical Division between January 2005 and December 2006 to evaluate an association between clomipramine treatment and glucose intolerance." | 7.80 | Diabetes mellitus associated with clomipramine treatment: a retrospective analysis. ( Cei, M; Cocciolo, M; Gambaccini, L; Mantellassi, M; Mumoli, N; Sabatini, S; Vitale, J, 2014) |
| " All of them met the ICD-10 criteria for anorexia nervosa and depressive episode and received an antidepressant medication with clomipramine or paroxetine." | 7.72 | [Paroxetine versus clomipramine in female adolescents suffering from anorexia nervosa and depressive episode--a retrospective study on tolerability, reasons for discontinuing the antidepressive treatment and different outcome measurements]. ( Roth, M; Schulze, U; Strobel, M; Warnke, A, 2004) |
| "We present a puzzling case of a 25-year-old depressive man suffering from seizures and visual hallucinations during clomipramine treatment with a high dose but causing a low serum concentration." | 7.70 | A puzzling case of seizures and visual hallucinations during clomipramine treatment with a high dose but causing a low serum concentration. ( Ohmori, O; Shinkai, T; Terao, T, 1999) |
| "An epileptic patient well controlled on valproic acid (VPA) developed a prolonged episode of status epilepticus 12 days after initiation of 75 mg of clomipramine (CMI) to treat depression." | 7.69 | Status epilepticus associated with the combination of valproic acid and clomipramine. ( DeToledo, JC; Haddad, H; Ramsay, RE, 1997) |
| "One schizophrenic and two manic-depressive patients who after the administration of zotepine, a new antipsychotic and antimanic drug, developed alopecia areata, a kind of autoimmune disease, are reported." | 7.68 | Three cases of alopecia areata induced by zotepine. ( Ishikura, T; Jibiki, I; Kubota, T, 1993) |
| "A 67-year-old man developed concurrent severe agranulocytosis and elevation of hepatic transaminases as a result of treatment with clomipramine." | 7.68 | Concurrent agranulocytosis and hepatitis secondary to clomipramine therapy. ( Alderman, CP; Atchison, MM; McNeece, JI, 1993) |
| "The case is described of a neonate who suffered from withdrawal symptoms within 24 hours after birth as a result of the use of clomipramine by the mother during pregnancy." | 7.68 | [Neonatal withdrawal symptoms following the use of clomipramine during pregnancy]. ( Boringa, JB; de Jong, GM; Touw, DJ, 1992) |
| "Two patients suffering from severe obsessive-compulsive disorder which had proven refractory to clomipramine and/or phenelzine treatment were successfully treated with fluoxetine, a new drug with a strong serotonin uptake inhibiting action." | 7.68 | Fluoxetine treatment of obsessive-compulsive disorder. ( Ledwidge, B; Solyom, C; Solyom, L, 1991) |
| "In the present study patients with a major depressive disorder were first subjected to total sleep deprivation (TSD) and then treated with clomipramine." | 7.68 | The effects of total sleep deprivation and subsequent treatment with clomipramine on depressive symptoms and sleep electroencephalography in patients with a major depressive disorder. ( Berger, M; Riemann, D, 1990) |
| "In October of 1989, a clustering of cases with eosinophilia lead to the identification of a new syndrome: The eosinophilia myalgia syndrome associated with the use of an L-tryptophan product." | 7.68 | Eosinophilia, myopathy, and neuropathy in a patient with repeated use of L-tryptophan. ( Goronzy, JJ; Weyand, CM, 1990) |
| "A 54-year old man developed pancytopenia after receiving clomipramine for a major depressive episode with psychotic features." | 7.67 | Clomipramine-induced pancytopenia. ( Grassetto, M; Magni, G; Silvestro, A; Urbani, A, 1987) |
| "Milnacipran is a new antidepressant with similar effects on the reuptake of noradrenaline and serotonin in vivo and in vitro." | 6.68 | A double-blind six months comparative study of milnacipran and clomipramine in major depressive disorder. ( Den Boer, JA; Steen, A, 1997) |
| "In 14 cases tremor and myoclonus occurred simultaneously, and 10 patients presented at the same time tremor plus myoclonus, diaphoresis and shivering." | 6.67 | Prospective evaluation of the serotonin syndrome in depressed inpatients treated with clomipramine. ( Adès, J; Lejoyeux, M; Rouillon, F, 1993) |
| " Safety was monitored weekly by recording body weight, blood pressure, pulse rate, temperature, physical conditions, laboratory tests, adverse experiences and concomitant medication." | 6.66 | Double-blind controlled study on the clinical efficacy and safety of fluoxetine vs clomipramine in the treatment of major depressive disorders. ( Agnoli, A; Manna, V; Martucci, N, 1989) |
| "Fengabine is a new GABAmimetic compound active in animal models predictive of antidepressant activity." | 6.66 | Fengabine, a new GABAmimetic agent in the treatment of depressive disorders: an overview of six double-blind studies versus tricyclics. ( Garreau, M; Magni, G; Orofiamma, B; Palminteri, R, 1989) |
| "In teeth with ligature, mean alveolar bone loss varied from 0." | 5.35 | Effect of neonatal clomipramine in the pathogenesis of ligature-induced periodontitis in Lewis rats. ( Gaio, EJ; Rosing, CK; Soletti, AC, 2009) |
| "Major depressive disorder in adolescents is characterized as treatment resistant, but a previous open-label trial of pulse intravenous clomipramine demonstrated rapid relief of depressive symptoms." | 5.08 | Pulse intravenous clomipramine for depressed adolescents: double-blind, controlled trial. ( Carson, SW; Deas-Nesmith, D; Sallee, FR; Sethuraman, G; Vrindavanam, NS, 1997) |
| "We examined the effects of long-term (six months) treatment with the serotonin potentiating tricyclic antidepressant clomipramine on several serotonergic parameters in panic disorder and depressive patients." | 5.08 | Effects of clomipramine on plasma amino acids and serotonergic parameters in panic disorder and depression. ( Fekkes, D; Pepplinkhuizen, L; Timmerman, L, 1997) |
| "There have been many attempts to find predictors of the therapeutic response to the clomipramine treatment of obsessive-compulsive disorder." | 5.07 | Predictors of treatment response in obsessive-compulsive disorder: multivariate analyses from a multicenter trial of clomipramine. ( Ackerman, DL; Bystritsky, A; Greenland, S; Katz, RJ; Morgenstern, H, 1994) |
| " Three tricyclic antidepressants examined (imipramine, clomipramine and desipramine) did not seem to have the side effect of pathological weight gain in the frequency distribution pattern." | 5.07 | Changes in the frequency distribution pattern of body weight in patients with major depression. ( Kato, T; Murashita, J; Shioiri, T; Takahashi, S; Yamada, N, 1993) |
| "A double-blind clinical trial of clomipramine versus phenelzine was carried out on 30 patients suffering from DSM-III obsessive-compulsive disorder." | 5.07 | Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial. ( Bulbena, A; Marcos, T; Menchón, JM; Olivares, J; Vallejo, J, 1992) |
| "Prolactin (PRL) and cortisol responses to oral administration of d-1 fenfluramine hydrochloride (60 mg) and placebo were examined in patients with endogenous major depressive disorder on three separate occasions: prior to treatment with clomipramine (CMI), after 4 weeks of CMI administration (175-250) mg/day), and 3 weeks after addition of lithium (Li) carbonate (serum level 0." | 5.07 | Effect of clomipramine and lithium on fenfluramine-induced hormone release in major depression. ( Gropp, C; Lerer, B; Newman, M; Shapira, B; Yagmur, MJ, 1992) |
| "Seventeen outpatients with panic anxiety and agoraphobia were treated with a low, flexible dose of clomipramine in an 8-week open trial." | 5.06 | Panic attacks and agoraphobia: low dose clomipramine treatment. ( Codner, S; Cohen, L; Gladic, D; Gloger, S; Grunhaus, L; O'Ryan, F, 1989) |
| "In a double-blind study on 22 patients with major depressive disorder the effects of lithium and clomipramine on signs and symptoms and on calcium and magnesium in plasma were compared." | 5.06 | Acute antidepressant effect of lithium is associated with fluctuation of calcium and magnesium in plasma. A double-blind study on the antidepressant effect of lithium and clomipramine. ( Fyrö, B; Linder, J; Pettersson, U; Werner, S, 1989) |
| "Most of the controlled studies on the efficacy of medical treatments of obsessive-compulsive disorder (OCD) have involved clomipramine, a tricyclic antidepressant reputed to have anti-obsessional properties." | 5.06 | Effects of imipramine on depression and obsessive-compulsive symptoms. ( Dugger, D; Foa, EB; Kozak, MJ; Steketee, G, 1987) |
| " Thirty-eight patients with episodic, chronic and atypical depressive disorder (DSM-III) were equally randomized to 6 weeks' treatment with either three daily doses of 100 mg moclobemide or 50 mg clomipramine." | 5.05 | Moclobemide and clomipramine in the treatment of depression. A randomized clinical trial. ( Holm, P; Larsen, JK; Mikkelsen, PL, 1984) |
| "The effect of clomipramine hydrochloride in severe obsessive-compulsive disorder (OCD) was compared with that of nortriptyline hydrochloride and placebo in a five-week randomized, double-blind trial." | 5.05 | Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial. ( Asberg, M; Cronholm, B; Jörnestedt, L; Thorén, P; Träskman, L, 1980) |
| " Results of short term clinical trials have shown paroxetine to be significantly superior to placebo, and comparable to amitriptyline, clomipramine, imipramine, dothiepin and mianserin in relieving symptoms associated with major depressive disorders." | 4.78 | Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness. ( Clissold, SP; Dechant, KL, 1991) |
| "In this retrospective analysis, we analyzed all clinical record data in our Medical Division between January 2005 and December 2006 to evaluate an association between clomipramine treatment and glucose intolerance." | 3.80 | Diabetes mellitus associated with clomipramine treatment: a retrospective analysis. ( Cei, M; Cocciolo, M; Gambaccini, L; Mantellassi, M; Mumoli, N; Sabatini, S; Vitale, J, 2014) |
| " During and at the end point of the chronic stress experiment, food consumption, body weight, adrenal gland, thymus and spleen indices, behavior scores, sucrose consumption, and stress hormone levels were measured." | 3.78 | Metabonomics approach to assessing the modulatory effects of St John's wort, ginsenosides, and clomipramine in experimental depression. ( Chen, T; Jia, W; Jia, Z; Jiang, T; Lin, J; Qiu, Y; Su, M; Wang, X; Xie, X; Zeng, C; Zhao, A; Zhao, T; Zhou, M, 2012) |
| " Risk of increasing suicidal ideation was higher in subjects taking antidepressants other than paroxetine (odds ratio: 1." | 3.77 | Clinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sample. ( Aubry, JM; Bertschy, G; Bondolfi, G; Gex-Fabry, M; Kosel, M; Malafosse, A; Perroud, N; Uher, R, 2011) |
| "We describe a 55-year-old woman with extensive digestive resection and recurrent depressive disorder resistant to oral clomipramine tablets but not to an oral solution of amitriptyline." | 3.77 | Therapeutic drug monitoring of clomipramine and amitriptyline in a depressed patient with upper digestive tract resection. ( Allilaire, JF; Couturier, PL; Goldwirt, L; Lambrey, S; Warot, D; Zahr, N, 2011) |
| "Treatment with clomipramine, a tricyclic antidepressant, has proved useful for obsessional patients either as an adjunct to behavior therapy or as a primary treatment for patients who are not amenable to behavioral interventions." | 3.75 | Obsessive-compulsive disorder. ( Insel, TR, 1985) |
| "The authors report an improvement in delusions and hallucinations after antidepressant treatment (Clomipramine) in a parkinsonian patient with psychosis and comorbid depression." | 3.74 | Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease. ( Bernardi, S; Meco, G, 2007) |
| " All of them met the ICD-10 criteria for anorexia nervosa and depressive episode and received an antidepressant medication with clomipramine or paroxetine." | 3.72 | [Paroxetine versus clomipramine in female adolescents suffering from anorexia nervosa and depressive episode--a retrospective study on tolerability, reasons for discontinuing the antidepressive treatment and different outcome measurements]. ( Roth, M; Schulze, U; Strobel, M; Warnke, A, 2004) |
| "We present a puzzling case of a 25-year-old depressive man suffering from seizures and visual hallucinations during clomipramine treatment with a high dose but causing a low serum concentration." | 3.70 | A puzzling case of seizures and visual hallucinations during clomipramine treatment with a high dose but causing a low serum concentration. ( Ohmori, O; Shinkai, T; Terao, T, 1999) |
| "The aim of this paper is to describe two cases of clomipramine-induced delirium." | 3.70 | Delirious episodes induced by intravenous administration of clomipramine associated with an acute increase in its plasma concentrations. ( Eto, S; Nakamura, J; Terao, T; Ueda, N; Yoshimura, R, 2000) |
| "An epileptic patient well controlled on valproic acid (VPA) developed a prolonged episode of status epilepticus 12 days after initiation of 75 mg of clomipramine (CMI) to treat depression." | 3.69 | Status epilepticus associated with the combination of valproic acid and clomipramine. ( DeToledo, JC; Haddad, H; Ramsay, RE, 1997) |
| "One schizophrenic and two manic-depressive patients who after the administration of zotepine, a new antipsychotic and antimanic drug, developed alopecia areata, a kind of autoimmune disease, are reported." | 3.68 | Three cases of alopecia areata induced by zotepine. ( Ishikura, T; Jibiki, I; Kubota, T, 1993) |
| "A 67-year-old man developed concurrent severe agranulocytosis and elevation of hepatic transaminases as a result of treatment with clomipramine." | 3.68 | Concurrent agranulocytosis and hepatitis secondary to clomipramine therapy. ( Alderman, CP; Atchison, MM; McNeece, JI, 1993) |
| "The case is described of a neonate who suffered from withdrawal symptoms within 24 hours after birth as a result of the use of clomipramine by the mother during pregnancy." | 3.68 | [Neonatal withdrawal symptoms following the use of clomipramine during pregnancy]. ( Boringa, JB; de Jong, GM; Touw, DJ, 1992) |
| "Performance on tasks tapping automatic and voluntary aspects of memory, attention, and motor speed was examined in 14 patients with major depressive disorder, before and after 3 weeks of treatment with clomipramine (150 mg/day), a potent serotonin and noradrenaline uptake blocker with anticholinergic side effects." | 3.68 | Memory effects of clomipramine treatment: relationship to CSF monoamine metabolites and drug concentrations in plasma. ( Asberg, M; Bartfai, A; Gustavsson, P; Mårtensson, B, 1991) |
| "Painful ejaculation following the administration of imipramine and clomipramine is described in four patients." | 3.68 | Painful ejaculation associated with antidepressants in four patients. ( Aizenberg, D; Hermesh, H; Karp, L; Weizman, A; Zemishlany, Z, 1991) |
| "Two patients suffering from severe obsessive-compulsive disorder which had proven refractory to clomipramine and/or phenelzine treatment were successfully treated with fluoxetine, a new drug with a strong serotonin uptake inhibiting action." | 3.68 | Fluoxetine treatment of obsessive-compulsive disorder. ( Ledwidge, B; Solyom, C; Solyom, L, 1991) |
| "In the present study patients with a major depressive disorder were first subjected to total sleep deprivation (TSD) and then treated with clomipramine." | 3.68 | The effects of total sleep deprivation and subsequent treatment with clomipramine on depressive symptoms and sleep electroencephalography in patients with a major depressive disorder. ( Berger, M; Riemann, D, 1990) |
| "In October of 1989, a clustering of cases with eosinophilia lead to the identification of a new syndrome: The eosinophilia myalgia syndrome associated with the use of an L-tryptophan product." | 3.68 | Eosinophilia, myopathy, and neuropathy in a patient with repeated use of L-tryptophan. ( Goronzy, JJ; Weyand, CM, 1990) |
| "Antidepressant therapy for panic attacks, exposure therapy for stimulus-dependent anxieties, and, to a lesser extent, clomipramine therapy for obsessive-compulsive symptoms have transformed the treatment of anxiety disorders and ushered in an era of rapid progress in research on anxiety and anxiety disorders." | 3.67 | New findings in anxiety. A synthesis for clinical practice in 1985. ( Curtis, GC, 1985) |
| "A 54-year old man developed pancytopenia after receiving clomipramine for a major depressive episode with psychotic features." | 3.67 | Clomipramine-induced pancytopenia. ( Grassetto, M; Magni, G; Silvestro, A; Urbani, A, 1987) |
| " Sixty-three depressed women (major depressive disorder) and 21 paranoid-hallucinatory women have been studied while on antidepressant (clomipramine) or neuroleptic (haloperidol) treatment, respectively." | 3.66 | The TSH-response to TRH: A possible predictor of outcome to antidepressant and neuroleptic treatment. ( Aschauer, H; Koinig, G; Langer, G; Resch, F; Schönbeck, G, 1983) |
| "ECGs and left ventricular systolic time intervals were studied in 26 patients suffering from major depressive disorder treated with clomipramine." | 3.66 | Cardiac effects of clomipramine treatment. ECG and left ventricular systolic time intervals. ( Brat, A; Faravelli, C; Franchi, F; Marchetti, G; Michelucci, A; Padeletti, L; Pastorino, A, 1983) |
| "Children and young adolescents with either depressive syndromes or enuresis were treated with clomipramine for periods of 1 to 9 months." | 3.66 | [Plasma level monitoring of psychotropic drugs in children. II -- Antidepressants (author's transl)]. ( Dugas, M; Durand, G; Le Heuzey, MF; Morselli, PL; Regnier, N; Rovei, V; Zarifian, E, 1982) |
| "Clomipramine was associated with a higher incidence of overall and treatment-related adverse events." | 2.71 | Fluvoxamine as effective as clomipramine against symptoms of severe depression: results from a multicentre, double-blind study. ( Barrelet, L; Keegstra, H; Zohar, J, 2003) |
| "Clomipramine (150 mg/day) was the reference treatment, and comparable treatments were citalopram (40 mg/day), paroxetine (30 mg/day), and moclobemide (400 mg/day)." | 2.71 | Are gender differences important for the clinical effects of antidepressants? ( Hildebrandt, MG; Kragh-Soerensen, P; Passchier, J; Stage, KB; Steyerberg, EW, 2003) |
| " There were more withdrawals due to adverse events in the clomipramine group than in the sertraline group (17% versus 12%)." | 2.69 | A double-blind study of the efficacy and safety of sertraline and clomipramine in outpatients with severe major depression. ( Blashko, C; Goger, J; Kosolowski, J; Lane, RM; Lépine, JP; Moles, MF; Probst, C; Scharfetter, B, 2000) |
| "Tachycardia was the most common change (36%)." | 2.68 | Electrocardiographic changes during desipramine and clomipramine treatment in children and adolescents. ( Allen, AJ; Hamburger, SD; Leonard, HL; Meyer, MC; Rapoport, JL; Richter, D; Swedo, SE; Tucker, E, 1995) |
| " EEG, ECG, and laboratory parameters and adverse effects reported by the patients, as well as global clinical improvement, were assessed." | 2.68 | Combination treatment with clomipramine and fluvoxamine: drug monitoring, safety, and tolerability data. ( Härtter, S; Hiemke, C; Leal, M; Szegedi, A; Wetzel, H, 1996) |
| "Clomipramine proved to be a useful treatment of depression in patients with probable AD." | 2.68 | A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease. ( Chemerinski, E; Leiguarda, R; Petracca, G; Starkstein, SE; Tesón, A, 1996) |
| "Milnacipran is a new antidepressive drug, a combined noradrenaline/serotonin (NA/5-HT) reuptake inhibitor, which has been suggested to be as effective as and better tolerated than tricyclic antidepressants." | 2.68 | Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression. ( Koponen, H; Leinonen, E; Lepola, U; Mehtonen, OP; Rimon, R, 1997) |
| "Milnacipran is a new antidepressant with similar effects on the reuptake of noradrenaline and serotonin in vivo and in vitro." | 2.68 | A double-blind six months comparative study of milnacipran and clomipramine in major depressive disorder. ( Den Boer, JA; Steen, A, 1997) |
| "Two different initial dosing regimens with clomipramine (CMI) were used to compare early response indicators and dose strategies." | 2.67 | Effect of pulse loading with clomipramine on EEG sleep. ( Ehlers, CL; Grochocinski, VJ; Kupfer, DJ; Miewald, JM; Perel, JM; Pollock, BG, 1994) |
| "Desmethylclomipramine levels were significantly greater in P-L nonresponders (p = 0." | 2.67 | Early response patterns associated with successful clomipramine treatment. ( Bowler, KA; Kupfer, DJ; Miewald, JM; Perel, JM; Pollock, BG, 1993) |
| "The pharmacokinetic parameters and the time course of the effect after acute oral administration of yohimbine on salivary secretion in patients treated with tricyclic antidepressants were investigated." | 2.67 | Pharmacokinetic study of yohimbine and its pharmacodynamic effects on salivary secretion in patients treated with tricyclic antidepressants. ( Bagheri, H; Berlan, M; Houin, G; Montastruc, JL; Picault, P; Schmitt, L, 1994) |
| "In 14 cases tremor and myoclonus occurred simultaneously, and 10 patients presented at the same time tremor plus myoclonus, diaphoresis and shivering." | 2.67 | Prospective evaluation of the serotonin syndrome in depressed inpatients treated with clomipramine. ( Adès, J; Lejoyeux, M; Rouillon, F, 1993) |
| "Moclobemide was compared with isocarboxazide and clomipramine in patients with depression." | 2.67 | Moclobemide in depression: a randomized, multicentre trial against isocarboxazide and clomipramine emphasizing atypical depression. ( Anderson, J; Bille, A; Christensen, EM; Gjerris, A; Holm, P; Høyer, E; Jensen, H; Langagergaard, A; Larsen, JK; Mejlhede, A, 1991) |
| " The frequency of adverse events in response to fluoxetine was lower than under clomipramine treatment." | 2.67 | [Efficacy and safety of fluoxetine versus clomipramine in ambulatory patients with a depressive syndrome in a clinical trial with private practitioners]. ( Dossenbach, M; Pakesch, G, 1991) |
| "Improvement in depression after total sleep deprivation (TSD) is, as a rule, followed by relapse after subsequent ad libitum sleep." | 2.67 | Total and partial sleep deprivation in clomipramine-treated endogenous depressives. ( Beersma, D; Elsenga, S; Van den Hoofdakker, RH, 1990) |
| "Moclobemide was compared with clomipramine for safety and efficacy in 2 groups of 15 patients each with endogenous depression." | 2.67 | Moclobemide versus clomipramine in the treatment of depression: a single-centre study, Federal Republic of Germany. ( Funke, HJ; Hellstern, K; Malanowski, H; Moritz, E, 1990) |
| "Patients with endogenous depression responded better to clomipramine, whereas nonendogenous disorders did better on moclobemide." | 2.67 | Moclobemide versus clomipramine in the treatment of depression: a double-blind multicentre study in Belgium. ( Berger, M; Burton, P; Cattiez, P; Defleur, J; Dierick, M; Franck, G; Hellstern, K; Hermans, W; Roelandts, A; Wolfrum, C, 1990) |
| " Although the bioavailability of parenteral clomipramine was greater, there were no significant differences in either efficacy or side effects between the two groups." | 2.66 | Acute antidepressant effect following pulse loading with intravenous and oral clomipramine. ( Kupfer, DJ; Nathan, RS; Perel, JM; Pollock, BG, 1989) |
| " Safety was monitored weekly by recording body weight, blood pressure, pulse rate, temperature, physical conditions, laboratory tests, adverse experiences and concomitant medication." | 2.66 | Double-blind controlled study on the clinical efficacy and safety of fluoxetine vs clomipramine in the treatment of major depressive disorders. ( Agnoli, A; Manna, V; Martucci, N, 1989) |
| "Fengabine is a new GABAmimetic compound active in animal models predictive of antidepressant activity." | 2.66 | Fengabine, a new GABAmimetic agent in the treatment of depressive disorders: an overview of six double-blind studies versus tricyclics. ( Garreau, M; Magni, G; Orofiamma, B; Palminteri, R, 1989) |
| " The study was conducted over a period of 28 days and the dosage of each substance, after being gradually increased, was stabilized at 150 mg." | 2.66 | CGP 12.103 A versus clomipramine in the treatment of depressed inpatients--results of a double-blind study. ( Binz, U; Hole, G; Steiner, B; Wendt, G; Wolfersdorf, M, 1988) |
| "In a double-blind study on 38 unselected depressive inpatients (19 per group) suffering from endogenous and psychogenic depression, oxaprotiline, a new tetracyclic compound, a hydroxylized maprotiline with a highly selective norepinephrine reuptake inhibition, was compared with clomipramine over a period of 28 days in a daily dosage of 150 mg." | 2.66 | Double-blind study of oxaprotiline versus clomipramine in the treatment of depressive inpatients. ( Binz, U; Hole, G; Metzger, R; Wendt, G; Wolfersdorf, M, 1987) |
| "A negative response to sleep deprivation, an increase in MAO activity as a result of sleep deprivation, the appearance of signs of fatigue (vigilance index) in the EEG after the first infusion as well as obvious autonomic symptoms before the start of treatment are indicative of a response to maprotiline." | 2.66 | Biological predictors of success of antidepressant drug therapy. ( Fähndrich, E, 1987) |
| "Orthostatic hypotension, the clinically most important side effect in treatment with tricyclic antidepressants, was investigated in a double-blind study with clomipramine and the selective serotonin reuptake inhibitor citalopram given for 5 weeks." | 2.66 | Orthostatic side effects of clomipramine and citalopram during treatment for depression. ( Christensen, P; Gram, LF; Kragh-Sørensen, P; Pedersen, OL; Thomsen, HY, 1985) |
| "Amineptine was however much better tolerated than clomipramine." | 2.66 | Amineptine in the management of the depressive syndromes. ( Bergamasco, B; Mailland, F; Scarzella, L; Scarzella, R, 1985) |
| "Fluvoxamine was superior to chlorimipramine in all the rating scales used without achieving statistical significance." | 2.65 | Fluvoxamine and chlorimipramine in endogenous depression. ( De Wilde, JE; Doogan, DP, 1982) |
| "Clomipramine was effective, safe, and well tolerated as compared to doxepin in the treatment of outpatients with neurotic depression." | 2.65 | A comparison of clomipramine and doxepin in neurotic depression. ( Horwitz, IM; Kornhaber, A, 1984) |
| " Patients in each group received chlorimipramine (50 mg/day), combined with L-5-HTP (300 mg/day) in Group A, and with placebo in Group B." | 2.65 | Treatment of depression with L-5-hydroxytryptophan combined with chlorimipramine, a double-blind study. ( Battistini, N; Borghesi, R; De Stefano, R; Iannuccelli, M; Nardini, M, 1983) |
| " Thirty-two patients with mixed depression received one or the other drug at the same daily dosage of 150 mg." | 2.65 | A double-blind comparative study of the clinical efficacy of fluvoxamine and chlorimipramine. ( Dick, P; Ferrero, E, 1983) |
| " In the first study the effects of a single daily dosage of between 100 and 300 mg of fluvoxamine were compared with those of chlorimipramine at a dosage of 50-150 mg daily in 43 out-patients with endogenous depression." | 2.65 | Clinical trials of fluvoxamine vs chlorimipramine with single and three times daily dosing. ( De Wilde, JE; Mertens, C; Wakelin, JS, 1983) |
| "1." | 2.65 | Fluvoxamine maleate, a serotonergic antidepressant; a comparison with chlorimipramine. ( Block, BA; Coleman, BS, 1982) |
| "Mianserin (60 mg daily) was compared with chlorimipramine (150 mg daily) in the treatment of 145 depressed in- and outpatients in four centres." | 2.65 | A double-blind multicentre trial comparing the efficacy and side-effects of mianserin and chlorimipramine in depressed in- and outpatients. ( Barres, M; Blum, A; Charbaut, J; Israel, L; Kammerer, T; Molczadzki, M; Pinder, RM; Rigaud, A; Stulemeijer, SM, 1980) |
| "In a previous study it was shown that in endogenous depression repeated sleep deprivation (SD) during clomipramine treatment resulted in rapid improvement after each SD." | 2.65 | Maintenance of therapeutic effects of total sleep deprivation by limitation of subsequent sleep. A pilot study. ( van Bemmel, AL; van den Hoofdakker, RH, 1981) |
| " In contrast, in 7 other patients receiving a dosage increasing to 150 mg per day at Day 7, mean plasma levels of C1 and DMC1 continued to rise during the entire treatment period." | 2.65 | Relationship between the plasma concentration of clomipramine and desmethylclomipramine in depressive patients and the clinical response. ( Allers, G; Jounet, JM; Vandel, B; Vandel, S; Volmat, R, 1982) |
| "Mirtazapine is a noradrenergic and specific serotonergic antidepressant, characterized by a unique pharmacologic profile, favorable pharmacokinetics, and proven efficacy and safety." | 2.40 | Mirtazapine: clinical advantages in the treatment of depression. ( Burrows, GD; Kremer, CM, 1997) |
| " In many instances, a knowledge of the drug metabolism status of a patient can be helpful in the selection of a drug and its dosage regimen, and in the prediction of possible drug/drug interactions when two or more drugs have to be administered concomitantly." | 2.39 | Polymorphism in the metabolism of drugs, including antidepressant drugs: comments on phenotyping. ( Coutts, RT, 1994) |
| "Depression has recently been referred to as a neuroimmune disease because it is characterized by inflammatory changes in the cerebral cortex and hippocampus." | 1.51 | Involvement of the microglial NLRP3 inflammasome in the anti-inflammatory effect of the antidepressant clomipramine. ( Gong, W; Halim, M; Li, B; Liu, Q; Ma, L; Ma, Y; Ren, Z; Wang, Y; Yu, J; Zhang, J; Zhang, S; Zhou, G; Zong, Y, 2019) |
| "Depression is a common mental disease affecting a lot of people of all ages around the world." | 1.51 | Zinc improves clomipramine effects on depressive and locomotor behavior and reverses its oxidative stress in rats. ( Abdelmelek, H; Ammari, M; Lassoued, A; Othman, H; Sakly, M, 2019) |
| "The observed withdrawal symptoms were too short a period of sleep after feeding (6), poor feeding (3), mild to severe tremors (6), hyperactive Moro reflex (3) and respiratory rate >60 breaths min(-1)." | 1.38 | Clomipramine concentration and withdrawal symptoms in 10 neonates. ( De Jong-van den Berg, LT; den Boon, J; Jansman, FG; Smit, JP; ter Horst, PG; van der Linde, S; van Lingen, RA; Wilffert, B, 2012) |
| "In teeth with ligature, mean alveolar bone loss varied from 0." | 1.35 | Effect of neonatal clomipramine in the pathogenesis of ligature-induced periodontitis in Lewis rats. ( Gaio, EJ; Rosing, CK; Soletti, AC, 2009) |
| " These effects were similar to the effects induced for subchronic and chronic administration of the antidepressant fluoxetine (5 mg/kg sc), a selective serotonin re-uptake inhibitor." | 1.33 | Antidepressant effects of nicotine and fluoxetine in an animal model of depression induced by neonatal treatment with clomipramine. ( Bonilla-Jaime, H; Vázquez-Palacios, G; Velázquez-Moctezuma, J, 2005) |
| "Treatment with fluoxetine reversed these changes, as in SC rats." | 1.32 | Alterations in voiding frequency and cystometry in the clomipramine induced model of endogenous depression and reversal with fluoxetine. ( Dean-McKinney, T; Klausner, AP; Lee, KS; Na, YG; Steers, WD; Tuttle, JB, 2003) |
| " Chronic administration of cyclic antidepressant drugs (citalopram, clomipramine, imipramine) decreased the immunoreactivity of the up-regulated G alpha i2 protein (31%)." | 1.30 | Density of guanine nucleotide-binding proteins in platelets of patients with major depression: increased abundance of the G alpha i2 subunit and down-regulation by antidepressant drug treatment. ( Balant, L; Busquets, X; Escribá, PV; García-Sevilla, JA; Guimón, J; Walzer, C, 1997) |
| "Because of a depressive syndrome, a 39-year-old patient received 20 mg fluoxetine per day." | 1.29 | [A case of rare side effects of certain antidepressive drugs]. ( Haenel, T; Stöckli, HR; Truog, P, 1995) |
| "Because human endogenous depression is associated with abnormal REM sleep and an elevated nocturnal Tb, these results give further support for the validity of the CLI model of depression and provide insight into the relationships among Tb, Ta, REM sleep and depression." | 1.29 | The effects of a 3-day increase of ambient temperature on body temperature and REM sleep in an animal model of depression. ( Rosenthal, MS; Vogel, GW, 1994) |
| "One theory about the pathogenesis of endogenous depression is that decreased serotonergic (5-HT) neurotransmission is involved in producing the disorder." | 1.29 | Decreased raphe unit activity in a rat model of endogenous depression. ( Neill, DB; Vogel, GW; Yavari, P, 1993) |
| " For the remaining 29, a comparison with 29 Caucasian patients treated by clomipramine (the two samples are matched for sex and age, and the variables of weight, dosage and drug association are controlled) shows no significantly higher plasma levels in the Beninese sample." | 1.28 | Clomipramine plasma levels among depressed outpatients in Benin, west Africa: drug compliance and comparison with Caucasian patients. ( Bertschy, G; Vandel, S, 1992) |
| "Clomipramine is a chlorinated tricyclic antidepressant commonly used in the treatment of depression (1)." | 1.28 | Toxic neonatal effects following maternal clomipramine therapy. ( Katz, EZ; Koren, G; Pastuszak, A; Schimmell, MS; Shaag, Y, 1991) |
| "clomipramine was studied in seven drug-free depressed patients and seven age-matched healthy control subjects." | 1.28 | Abnormal neuroendocrine responsivity to acute i.v. clomipramine challenge in depressed patients. ( Ekstrom, D; Golden, RN; Hicks, R; Hsiao, JK; Lane, E; Potter, WZ; Rogers, S, 1990) |
| "This suggests that an animal model of endogenous depression should show diminished sexual activity." | 1.28 | Diminished sexual activity in a new animal model of endogenous depression. ( Hagler, M; Hennessey, A; Kors, D; Neill, D; Vogel, G, 1990) |
| " Potential implications of the proposed model-based approach include adaptation of the dosage regimen to individual characteristics at the very beginning of antidepressant therapy, and early detection of patients with impaired metabolising capacities." | 1.28 | Clomipramine metabolism. Model-based analysis of variability factors from drug monitoring data. ( Balant, LP; Balant-Gorgia, AE; Garrone, G; Gex-Fabry, M, 1990) |
| "Two cases of agranulocytosis occurring after addition of a butyrophenone to a course of phenothiazine treatment are reported and possible mechanisms for this interaction are discussed." | 1.28 | Two cases of agranulocytosis on addition of a butyrophenone to a long-standing course of phenothiazine treatment. ( Kehoe, R; Young, A, 1989) |
| " A tapering schedule was carried out during a 12-day stay in the hospital in which the diazepam dosage was reduced by a fixed quantity every day, corresponding to about ten percent of the initial dosage." | 1.28 | Panic attacks and major depression after discontinuation of long-term diazepam abuse. ( Magni, G; Schifano, F, 1989) |
| "Total sleep deprivation (TSD) in depressive patients is known to produce sudden changes in mood, but the factors involved in these mood changes are poorly understood." | 1.28 | Observed behavior as a predictor of the response to sleep deprivation in depressed patients. ( Beersma, DG; Bouhuys, AL; van den Hoofdakker, RH, 1989) |
| " All patients were markedly improved when the daily dosage of the antidepressant was reduced with a simultaneous decrease of the blood concentrations." | 1.28 | High blood concentrations of imipramine or clomipramine and therapeutic failure: a case report study using drug monitoring data. ( Balant, LP; Balant-Gorgia, AE; Garrone, G, 1989) |
| "Ninety five patients with unipolar depression who received lithium therapy for one year were also studied." | 1.27 | Classification of depression and response to antidepressive therapies. ( Abou-Saleh, MT; Coppen, A, 1983) |
| "The reaction to sleep deprivation (SD) and the changes in MAO activity resulting from sleep deprivation were tested on 60 depressive patients as predictors for antidepressant drug treatment." | 1.27 | [When do I give which antidepressant in the individual case?]. ( Fähndrich, E, 1984) |
| "Although there have been previous reports of decreased sexual capacity as a side effect of antidepressants (1-3), the authors know of no previous records of increased capacity of the type described in the following reports, or of reports of side effects associated with yawning." | 1.27 | Unusual side effects of clomipramine associated with yawning. ( Forsythe, RG; Kapkin, IA; McLean, JD, 1983) |
| "25 patients with therapy-resistant depressive syndromes of various origins were treated by the infusion of high Hydiphen doses, a very effective thymoleptic drug with no dissociation between its drive increasing and spirit raising actions." | 1.27 | [Report of experiences with high dosage Hydiphen infusion treatment of depressive syndromes]. ( Dreves, B; Haiduk, A; Manthey, I; Schmieter, K, 1984) |
| "Clomipramine (CMI) was administered to eight patients, either as an antidepressive drug or, in two patients, as an antalgic drug (average age: 54 y." | 1.27 | [Plasma levels of desmethylclomipramine and clomipramine at steady-state in the morning. Correlative analysis and prediction of theoretical blood clomipramine]. ( Aymard, N; Champiat, JC; des Lauriers, A, 1983) |
| " Long-term administration of clomipramine was associated with decreases in platelet alpha 2-adrenoceptor densities which correlated with the duration of treatment." | 1.27 | Enhanced binding of [3H] (-) adrenaline to platelets of depressed patients with melancholia: effect of long-term clomipramine treatment. ( Alvarez, E; Casas, M; Fuster, MJ; Garcia-Sevilla, JA; Udina, C, 1987) |
| "Fengabine (SL 79." | 1.27 | Fengabine, a novel antidepressant GABAergic agent. I. Activity in models for antidepressant drugs and psychopharmacological profile. ( Bartholini, G; Depoortere, H; Lloyd, KG; Sanger, D; Zivkovic, B, 1987) |
| "Lithium carbonate (600 mg/day) was then resumed." | 1.27 | [Rapid response of a disorder to the addition of lithium carbonate: panic resistant to tricyclic antidepressants]. ( Cournoyer, J, 1986) |
| "Seven patients suffering from severe endogenous depression who had proven resistant to lengthy trials of treatment with tricyclic and other antidepressants are described." | 1.27 | Clomipramine, tryptophan and lithium in combination for resistant endogenous depression: seven case studies. ( Bridges, PK; Hale, AS; Procter, AW, 1987) |
| "After four weeks 66% of the endogenous depressions and 53% of the exhaustion depressions had completely regressed." | 1.26 | [Management of treatment-resistant depression without ECT (author's transl)]. ( Adams, C; Gastpar, M; Kielholz, P; Terzani, S, 1981) |
| "Ten patients with a vital depressive syndrome were treated for 4 weeks with clomipramine (CI), five receiving the drug by mouth and five receiving it first intramuscularly and then by mouth." | 1.26 | Pharmacokinetics of clomipramine in depressive patients. ( de Cuyper, HJ; de Zeeuw, RA; Mulder-Hajonides, WR; van Praag, HM; Westenberg, HG, 1981) |
| "26 patients with depressive syndrome were included in a double-blind study; 13 patients were treated with clomipramine (CI) + placebo (P), and 13 with CI + PL." | 1.26 | Phospholipid liposomes in depression: a double-blind study versus placebo. ( Allegro, A; Casacchia, M; Cusimano, G; Di Cesare, E; Marola, W; Meco, G; Pirro, R, 1982) |
| " The third patient manipulated dosage times to diminish the orgastic problem." | 1.26 | Sexual dysfunction and clomipramine. ( Einarson, TR; Quirk, KC, 1982) |
| "Clomipramine is a tricyclic antidepressant widely used." | 1.26 | [Clomipramine and desmethylclomipramine: relationship between plasma levels and clinical effect (author's transl)]. ( Allers, G; Jounet, JM; Vandel, B; Vandel, S; Volmat, R, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 156 (40.73) | 18.7374 |
| 1990's | 170 (44.39) | 18.2507 |
| 2000's | 39 (10.18) | 29.6817 |
| 2010's | 17 (4.44) | 24.3611 |
| 2020's | 1 (0.26) | 2.80 |
| Authors | Studies |
|---|---|
| Faucher, P | 1 |
| Dries, A | 1 |
| Mousset, PY | 1 |
| Leboyer, M | 2 |
| Dore, J | 1 |
| Beracochea, D | 1 |
| Brown, JT | 1 |
| Schneiderhan, M | 1 |
| Eum, S | 1 |
| Bishop, JR | 1 |
| Faye, A | 1 |
| Kirpekar, V | 1 |
| Tadke, R | 1 |
| Gawande, S | 1 |
| Bhave, S | 1 |
| Tofte, A | 1 |
| Narang, P | 1 |
| Lippmann, S | 1 |
| Gong, W | 1 |
| Zhang, S | 1 |
| Zong, Y | 1 |
| Halim, M | 1 |
| Ren, Z | 1 |
| Wang, Y | 1 |
| Ma, Y | 1 |
| Li, B | 1 |
| Ma, L | 1 |
| Zhou, G | 1 |
| Yu, J | 1 |
| Zhang, J | 1 |
| Liu, Q | 1 |
| Othman, H | 1 |
| Ammari, M | 1 |
| Lassoued, A | 1 |
| Sakly, M | 1 |
| Abdelmelek, H | 1 |
| Mumoli, N | 1 |
| Cocciolo, M | 1 |
| Vitale, J | 1 |
| Mantellassi, M | 1 |
| Sabatini, S | 1 |
| Gambaccini, L | 1 |
| Cei, M | 1 |
| Kar, SK | 1 |
| Garg, K | 1 |
| Soletti, AC | 1 |
| Gaio, EJ | 1 |
| Rosing, CK | 1 |
| Kuramochi, M | 1 |
| Nakamura, S | 1 |
| Matrisciano, F | 1 |
| Modafferi, AM | 1 |
| Togna, GI | 1 |
| Barone, Y | 1 |
| Pinna, G | 1 |
| Nicoletti, F | 1 |
| Scaccianoce, S | 1 |
| Lagus, M | 1 |
| Gass, N | 1 |
| Saharinen, J | 1 |
| Saarela, J | 1 |
| Porkka-Heiskanen, T | 2 |
| Paunio, T | 1 |
| Lykouras, L | 1 |
| Markianos, M | 1 |
| Hatzimanolis, Y | 1 |
| Perroud, N | 1 |
| Bondolfi, G | 2 |
| Uher, R | 1 |
| Gex-Fabry, M | 3 |
| Aubry, JM | 1 |
| Bertschy, G | 4 |
| Malafosse, A | 2 |
| Kosel, M | 2 |
| Couturier, PL | 1 |
| Zahr, N | 1 |
| Goldwirt, L | 1 |
| Warot, D | 1 |
| Allilaire, JF | 3 |
| Lambrey, S | 1 |
| ter Horst, PG | 1 |
| van der Linde, S | 1 |
| Smit, JP | 1 |
| den Boon, J | 1 |
| van Lingen, RA | 1 |
| Jansman, FG | 1 |
| De Jong-van den Berg, LT | 1 |
| Wilffert, B | 1 |
| McDowell, AL | 1 |
| Strohl, KP | 1 |
| Feng, P | 1 |
| Savelyev, SA | 1 |
| Rantamäki, T | 1 |
| Rytkönen, KM | 1 |
| Castren, E | 1 |
| Wang, X | 1 |
| Zeng, C | 1 |
| Lin, J | 1 |
| Chen, T | 1 |
| Zhao, T | 1 |
| Jia, Z | 1 |
| Xie, X | 1 |
| Qiu, Y | 1 |
| Su, M | 1 |
| Jiang, T | 1 |
| Zhou, M | 1 |
| Zhao, A | 1 |
| Jia, W | 1 |
| Licht, RW | 1 |
| van Kampen, M | 1 |
| Kramer, M | 1 |
| Hiemke, C | 3 |
| Flügge, G | 1 |
| Fuchs, E | 1 |
| Mavanji, V | 1 |
| Datta, S | 1 |
| Galeotti, N | 1 |
| Bartolini, A | 1 |
| Ghelardini, C | 1 |
| Ventura, R | 1 |
| Cabib, S | 1 |
| Puglisi-Allegra, S | 1 |
| Yamada, J | 1 |
| Sugimoto, Y | 1 |
| Braconnier, A | 1 |
| Le Coent, R | 1 |
| Cohen, D | 1 |
| Zohar, J | 2 |
| Keegstra, H | 1 |
| Barrelet, L | 1 |
| Mulder, RT | 5 |
| Watkins, WG | 1 |
| Joyce, PR | 6 |
| Luty, SE | 1 |
| Januel, D | 1 |
| Poirier, MF | 3 |
| D'alche-Biree, F | 1 |
| Dib, M | 1 |
| Olié, JP | 2 |
| Hildebrandt, MG | 1 |
| Steyerberg, EW | 1 |
| Stage, KB | 3 |
| Passchier, J | 1 |
| Kragh-Soerensen, P | 1 |
| Lee, KS | 1 |
| Na, YG | 1 |
| Dean-McKinney, T | 1 |
| Klausner, AP | 1 |
| Tuttle, JB | 1 |
| Steers, WD | 1 |
| Suzuki, E | 1 |
| Yoshida, Y | 1 |
| Shibuya, A | 1 |
| Miyaoka, H | 1 |
| Kozian, R | 1 |
| Cordner, AP | 1 |
| Herwood, MB | 1 |
| Helmreich, DL | 1 |
| Parfitt, DB | 1 |
| Vandel, P | 1 |
| Haffen, E | 1 |
| Nezelof, S | 2 |
| Broly, F | 2 |
| Kantelip, JP | 1 |
| Sechter, D | 3 |
| Avella, J | 1 |
| Lehrer, M | 1 |
| Katz, M | 1 |
| Minden, E | 1 |
| Strobel, M | 1 |
| Warnke, A | 1 |
| Roth, M | 2 |
| Schulze, U | 1 |
| Vázquez-Palacios, G | 1 |
| Bonilla-Jaime, H | 1 |
| Velázquez-Moctezuma, J | 2 |
| Inoue, T | 1 |
| Kitaichi, T | 1 |
| Ogawa, T | 1 |
| Meco, G | 2 |
| Bernardi, S | 1 |
| Gruwez, B | 1 |
| Dauphin, A | 1 |
| Tod, M | 1 |
| Bajbouj, M | 1 |
| Gallinat, J | 1 |
| Lang, UE | 1 |
| Hellen, F | 1 |
| Vesper, J | 1 |
| Lisanby, SH | 1 |
| Danker-Hopfe, H | 1 |
| Neu, P | 1 |
| Leggio, GM | 2 |
| Micale, V | 2 |
| Drago, F | 2 |
| Bhagya, V | 1 |
| Srikumar, BN | 1 |
| Raju, TR | 1 |
| Shankaranarayana Rao, BS | 1 |
| Pfuhlmann, B | 1 |
| Gerlach, M | 1 |
| Burger, R | 1 |
| Gonska, S | 1 |
| Unterecker, S | 1 |
| Jabs, B | 1 |
| Riederer, P | 1 |
| Deckert, J | 1 |
| Yang, LM | 1 |
| Hu, B | 1 |
| Xia, YH | 1 |
| Zhang, BL | 1 |
| Zhao, H | 1 |
| Bun'kova, KM | 1 |
| Tamburella, A | 1 |
| Mazzola, C | 1 |
| Li Volsi, V | 1 |
| Lecrubier, Y | 3 |
| Puech, AJ | 1 |
| Frances, H | 1 |
| Jouvent, R | 4 |
| Widlöcher, D | 3 |
| Simon, P | 3 |
| Kielholz, P | 4 |
| Terzani, S | 2 |
| Gastpar, M | 4 |
| Adams, C | 2 |
| Zapletálek, M | 2 |
| Zbytovský, J | 2 |
| Libiger, J | 1 |
| Pazdírek, S | 1 |
| Cápová, E | 1 |
| Pöldinger, W | 1 |
| Alac, S | 1 |
| Krebs-Roubicek, E | 1 |
| Bertilsson, L | 1 |
| Tybring, G | 1 |
| Braithwaite, R | 1 |
| Träskman-Bendz, L | 1 |
| Asberg, M | 4 |
| Stewart, JW | 1 |
| Quitkin, F | 1 |
| Fyer, A | 1 |
| Rifkin, A | 1 |
| McGrath, P | 1 |
| Liebowitz, M | 1 |
| Rosnick, L | 1 |
| Klein, DF | 1 |
| Faravelli, C | 5 |
| Ballerini, A | 3 |
| Broadhurst, AD | 3 |
| Das, M | 3 |
| De Wilde, JE | 2 |
| Doogan, DP | 1 |
| Lechin, F | 1 |
| Van der Dijs, B | 1 |
| Gómez, F | 1 |
| Arocha, L | 1 |
| Acosta, E | 1 |
| Lechin, E | 1 |
| Abou-Saleh, MT | 1 |
| Coppen, A | 1 |
| Ambonetti, A | 2 |
| Rapisarda, V | 1 |
| Bongiorno, G | 1 |
| Goyot, C | 2 |
| Grenier, J | 2 |
| Hug, R | 1 |
| Cesková, E | 2 |
| Náhunek, K | 2 |
| Rysánek, R | 1 |
| Svestka, J | 2 |
| Marks, I | 1 |
| Lader, M | 1 |
| Boom, AJ | 1 |
| Hevest, HP | 1 |
| Krypsin-Exner, K | 1 |
| van der Poel, FW | 1 |
| Möller, HJ | 3 |
| Kissling, W | 3 |
| Herberger, B | 1 |
| Kuss, HJ | 1 |
| Kornhaber, A | 1 |
| Horwitz, IM | 1 |
| Puech, A | 1 |
| Møller, SE | 5 |
| Larsen, OB | 1 |
| Gram, LF | 5 |
| Kragh-Sørensen, P | 5 |
| Kristensen, CB | 1 |
| Møller, M | 1 |
| Pedersen, OL | 2 |
| Thayssen, P | 1 |
| Nardini, M | 1 |
| De Stefano, R | 1 |
| Iannuccelli, M | 1 |
| Borghesi, R | 1 |
| Battistini, N | 1 |
| Dimitriou, E | 1 |
| Paraschos, A | 1 |
| Logothetis, J | 1 |
| Larsen, JK | 4 |
| Holm, P | 3 |
| Mikkelsen, PL | 1 |
| Dick, P | 1 |
| Ferrero, E | 1 |
| Mertens, C | 1 |
| Wakelin, JS | 1 |
| Langer, G | 5 |
| Aschauer, H | 3 |
| Koinig, G | 5 |
| Resch, F | 2 |
| Schönbeck, G | 4 |
| Keshavan, MS | 1 |
| Dittrich, R | 1 |
| Bech, P | 6 |
| Allerup, P | 1 |
| Reisby, N | 3 |
| Wålinder, J | 1 |
| Carlsson, A | 1 |
| Persson, R | 1 |
| Ortmann, J | 1 |
| Elley, J | 1 |
| Krautwald, O | 1 |
| Klein, E | 1 |
| Hefez, A | 1 |
| Lavie, P | 1 |
| Fähndrich, E | 7 |
| Insel, TR | 3 |
| Mueller, EA | 1 |
| Gillin, JC | 1 |
| Siever, LJ | 1 |
| Murphy, DL | 2 |
| Bottermann, P | 2 |
| Yufu, N | 1 |
| Itoh, M | 1 |
| Notomi, A | 1 |
| Nakao, H | 1 |
| Brat, A | 1 |
| Marchetti, G | 1 |
| Franchi, F | 1 |
| Padeletti, L | 1 |
| Michelucci, A | 1 |
| Pastorino, A | 1 |
| McLean, JD | 1 |
| Forsythe, RG | 1 |
| Kapkin, IA | 1 |
| Grillon, C | 1 |
| Bathien, N | 1 |
| Dreves, B | 1 |
| Manthey, I | 1 |
| Schmieter, K | 1 |
| Haiduk, A | 1 |
| Cowe, L | 1 |
| Lloyd, DJ | 1 |
| Dawling, S | 1 |
| Coleman, BS | 1 |
| Block, BA | 1 |
| Kolomazník, M | 1 |
| Hronek, J | 1 |
| Petránová, T | 1 |
| Jankových, V | 1 |
| Karásková, M | 1 |
| Kryl, L | 1 |
| Stern, R | 1 |
| Müller-Oerlinghausen, B | 1 |
| De Biase, L | 1 |
| La Malfa, G | 1 |
| Champiat, JC | 1 |
| Aymard, N | 3 |
| des Lauriers, A | 1 |
| Brown, WA | 2 |
| Qualls, CB | 2 |
| de Cuyper, HJ | 1 |
| van Praag, HM | 1 |
| Mulder-Hajonides, WR | 1 |
| Westenberg, HG | 1 |
| de Zeeuw, RA | 1 |
| Pinder, RM | 1 |
| Blum, A | 1 |
| Stulemeijer, SM | 1 |
| Barres, M | 1 |
| Molczadzki, M | 1 |
| Rigaud, A | 1 |
| Charbaut, J | 1 |
| Israel, L | 1 |
| Kammerer, T | 1 |
| Ananth, J | 2 |
| Pecknold, JC | 1 |
| van den Steen, N | 1 |
| Engelsmann, F | 1 |
| van Bemmel, AL | 1 |
| van den Hoofdakker, RH | 6 |
| de Buck, RP | 1 |
| Mawson, D | 1 |
| Marks, IM | 1 |
| Ramm, L | 1 |
| Küfferle, B | 1 |
| Grünberger, J | 1 |
| Ostergaard, GZ | 1 |
| Pedersen, SE | 1 |
| Dutt, JE | 1 |
| Yassa, R | 1 |
| Vandel, B | 3 |
| Vandel, S | 5 |
| Jounet, JM | 2 |
| Allers, G | 2 |
| Volmat, R | 2 |
| Kudrnová, K | 1 |
| Soucek, K | 1 |
| Dugas, M | 1 |
| Zarifian, E | 1 |
| Le Heuzey, MF | 1 |
| Regnier, N | 1 |
| Durand, G | 1 |
| Rovei, V | 1 |
| Morselli, PL | 2 |
| Casacchia, M | 1 |
| Pirro, R | 1 |
| Di Cesare, E | 1 |
| Allegro, A | 1 |
| Cusimano, G | 1 |
| Marola, W | 1 |
| Quirk, KC | 1 |
| Einarson, TR | 1 |
| Laakmann, G | 1 |
| Haier, RJ | 1 |
| Lange, E | 1 |
| Riedel, C | 1 |
| König, L | 1 |
| Liefke, T | 1 |
| Kursawe, H | 1 |
| Agnoli, A | 2 |
| Martucci, N | 2 |
| Ciabatti, P | 1 |
| Caratozzolo, P | 1 |
| Rulli, V | 1 |
| Sollecito, A | 1 |
| Ehsanullah, RS | 1 |
| Thorén, P | 1 |
| Cronholm, B | 1 |
| Jörnestedt, L | 1 |
| Träskman, L | 1 |
| Linnoila, M | 1 |
| Seppala, T | 1 |
| Mattila, MJ | 1 |
| Vihko, R | 1 |
| Pakarinen, A | 1 |
| Skinner, T | 1 |
| Rafaelsen, OJ | 1 |
| Serfaty, MA | 1 |
| McCluskey, S | 1 |
| Eccleston, D | 1 |
| Müller, B | 1 |
| Andersen, JV | 1 |
| Buch, D | 1 |
| Bellino, S | 1 |
| Barzega, G | 1 |
| Bogetto, F | 1 |
| Maina, G | 1 |
| Ravizza, L | 1 |
| Baischer, W | 1 |
| Hartmann, B | 1 |
| Huber, J | 1 |
| Harris, MG | 1 |
| Benfield, P | 1 |
| Lamard, L | 1 |
| Pérault, MC | 1 |
| Bouquet, S | 2 |
| Guibert, S | 1 |
| Kupfer, DJ | 8 |
| Pollock, BG | 8 |
| Perel, JM | 8 |
| Miewald, JM | 4 |
| Grochocinski, VJ | 1 |
| Ehlers, CL | 3 |
| Sullivan, PF | 3 |
| Kilonzo, GP | 1 |
| Kaaya, SF | 1 |
| Rweikiza, JK | 1 |
| Kassam, M | 1 |
| Moshi, G | 1 |
| Ulrich, G | 2 |
| Haug, HJ | 2 |
| Wilens, TE | 1 |
| Spencer, T | 1 |
| Biederman, J | 1 |
| Wozniak, J | 1 |
| Connor, D | 1 |
| Cano-Muñoz, JL | 1 |
| Montejo-Iglesias, ML | 2 |
| Yañez-Saez, RM | 1 |
| Gálvez-Borrero, IM | 1 |
| Haenel, T | 2 |
| Stöckli, HR | 1 |
| Truog, P | 1 |
| Kubota, T | 1 |
| Ishikura, T | 1 |
| Jibiki, I | 1 |
| van Hoof, JJ | 1 |
| Hulstijn, W | 1 |
| van Mier, H | 1 |
| Pagen, M | 1 |
| Ackerman, DL | 1 |
| Greenland, S | 1 |
| Bystritsky, A | 2 |
| Morgenstern, H | 1 |
| Katz, RJ | 2 |
| Rosenthal, MS | 1 |
| Vogel, GW | 2 |
| Bocksberger, JP | 1 |
| Gauthey, L | 1 |
| Balant-Gorgia, AE | 6 |
| Waikar, SV | 1 |
| Honore, P | 1 |
| Carbuccia, I | 1 |
| Bowler, KA | 1 |
| Noguchi, T | 1 |
| Shimoda, K | 2 |
| Takahashi, S | 2 |
| Bagheri, H | 1 |
| Picault, P | 1 |
| Schmitt, L | 1 |
| Houin, G | 1 |
| Berlan, M | 1 |
| Montastruc, JL | 1 |
| Coutts, RT | 1 |
| Alderman, CP | 1 |
| Atchison, MM | 1 |
| McNeece, JI | 1 |
| Cloninger, CR | 1 |
| Stöger, H | 1 |
| Wilders-Truschnig, M | 1 |
| Schmid, M | 1 |
| Petek, W | 1 |
| Samonigg, H | 1 |
| Weizman, R | 1 |
| Laor, N | 1 |
| Podliszewski, E | 1 |
| Notti, I | 1 |
| Djaldetti, M | 1 |
| Bessler, H | 1 |
| Kojima, H | 1 |
| Terao, T | 5 |
| Yoshimura, R | 2 |
| Nierenberg, DW | 1 |
| Semprebon, M | 1 |
| Tollefson, GD | 1 |
| Souetre, E | 2 |
| Thomander, L | 1 |
| Potvin, JH | 1 |
| Mine, K | 1 |
| Okada, M | 1 |
| Mishima, N | 1 |
| Fujiwara, M | 1 |
| Nakagawa, T | 1 |
| Shioiri, T | 1 |
| Kato, T | 1 |
| Murashita, J | 1 |
| Yamada, N | 1 |
| Lejoyeux, M | 2 |
| Rouillon, F | 1 |
| Adès, J | 2 |
| Balon, R | 1 |
| Yeragani, VK | 1 |
| Pohl, R | 1 |
| Ramesh, C | 1 |
| Yazici, O | 1 |
| Aricioğlu, F | 1 |
| Gürvit, G | 1 |
| Uçok, A | 1 |
| Taştaban, Y | 1 |
| Canberk, O | 1 |
| Ozgüroğlu, M | 1 |
| Durat, T | 1 |
| Sahin, D | 1 |
| Yavari, P | 1 |
| Neill, DB | 1 |
| Phillips, KA | 2 |
| McElroy, SL | 1 |
| Keck, PE | 1 |
| Pope, HG | 2 |
| Hudson, JI | 1 |
| Vila, G | 1 |
| Mouren-Simeoni, MC | 1 |
| Shapira, B | 3 |
| Cohen, J | 1 |
| Newman, ME | 2 |
| Lerer, B | 3 |
| Buchholtz-Hansen, PE | 1 |
| Wang, AG | 1 |
| Browne, M | 1 |
| Horn, E | 1 |
| Jones, TT | 1 |
| Leonard, HL | 1 |
| Meyer, MC | 1 |
| Swedo, SE | 1 |
| Richter, D | 1 |
| Hamburger, SD | 1 |
| Allen, AJ | 1 |
| Rapoport, JL | 2 |
| Tucker, E | 1 |
| Iancu, I | 1 |
| Kotler, M | 1 |
| Bleich, A | 1 |
| Lepkifker, E | 1 |
| Szegedi, A | 1 |
| Wetzel, H | 1 |
| Leal, M | 1 |
| Härtter, S | 2 |
| Rowe, JB | 1 |
| Baumann, P | 4 |
| Bonin, B | 2 |
| Francois, T | 1 |
| Bizouard, P | 2 |
| Martin, P | 1 |
| Lozet, H | 1 |
| Monteban, H | 1 |
| Conus, P | 1 |
| Eap, CB | 2 |
| Macciardi, F | 1 |
| Pezard, L | 1 |
| Nandrino, JL | 1 |
| Renault, B | 1 |
| el Massioui, F | 1 |
| Müller, J | 1 |
| Varela, F | 1 |
| Martinerie, J | 1 |
| Havstad, JW | 1 |
| Fuglum, E | 1 |
| Rosenberg, C | 1 |
| Damsbo, N | 1 |
| Stage, K | 1 |
| Lauritzen, L | 2 |
| Pedarriosse, AM | 2 |
| Payan, C | 3 |
| Schmid-Burgk, W | 1 |
| Stabl, M | 1 |
| Ries, C | 1 |
| Balant, LP | 4 |
| Petracca, G | 1 |
| Tesón, A | 1 |
| Chemerinski, E | 1 |
| Leiguarda, R | 1 |
| Starkstein, SE | 1 |
| Spreux-Varoquaux, O | 2 |
| Gailledreau, J | 1 |
| Vanier, B | 1 |
| Bothua, D | 1 |
| Plas, J | 1 |
| Chevalier, JF | 1 |
| Advenier, C | 1 |
| Pays, M | 1 |
| Brion, S | 1 |
| Oakley-Browne, MA | 1 |
| DeToledo, JC | 1 |
| Haddad, H | 1 |
| Ramsay, RE | 1 |
| Kudo, K | 1 |
| Sasaki, I | 1 |
| Tsuchiyama, K | 2 |
| Akiyoshi, J | 1 |
| Nagayama, H | 4 |
| Fujii, I | 1 |
| Parker, G | 1 |
| Barrett, E | 1 |
| Nair, NP | 1 |
| Gjerris, A | 2 |
| Burrows, GD | 1 |
| Kremer, CM | 1 |
| Ravindran, AV | 1 |
| Judge, R | 1 |
| Hunter, BN | 1 |
| Bray, J | 1 |
| Morton, NH | 1 |
| Sallee, FR | 3 |
| Vrindavanam, NS | 2 |
| Deas-Nesmith, D | 2 |
| Carson, SW | 2 |
| Sethuraman, G | 2 |
| Sommer, BR | 1 |
| Fekkes, D | 1 |
| Timmerman, L | 1 |
| Pepplinkhuizen, L | 1 |
| Amen, DG | 1 |
| Waugh, ME | 1 |
| Amsterdam, JD | 1 |
| García-España, F | 1 |
| Rosenzweig, M | 1 |
| Banger, M | 1 |
| Hermes, B | 1 |
| García-Sevilla, JA | 2 |
| Walzer, C | 1 |
| Busquets, X | 1 |
| Escribá, PV | 1 |
| Balant, L | 2 |
| Guimón, J | 1 |
| Dominguez, RA | 1 |
| Puig, A | 1 |
| Yonkers, KA | 1 |
| Leinonen, E | 1 |
| Lepola, U | 1 |
| Koponen, H | 1 |
| Mehtonen, OP | 1 |
| Rimon, R | 1 |
| Steen, A | 1 |
| Den Boer, JA | 1 |
| Palazzolo, J | 1 |
| Welch, CP | 1 |
| Tweed, JA | 1 |
| Smithers, A | 1 |
| Gostick, NK | 1 |
| Raniwalla, J | 1 |
| O'Sullivan, RL | 1 |
| Antelman, SM | 2 |
| Gershon, S | 1 |
| Gillman, PK | 1 |
| Schaller, JL | 1 |
| Behar, D | 1 |
| Chamberlain, T | 1 |
| Pérez, V | 1 |
| Bel, N | 1 |
| Celada, P | 1 |
| Ortiz, J | 1 |
| Alvarez, E | 4 |
| Artigas, F | 2 |
| Karege, F | 1 |
| Bovier, P | 1 |
| Stepanian, R | 1 |
| Chabrol, H | 1 |
| Peresson, G | 1 |
| Le Houezec, J | 1 |
| Mikkelsen, H | 1 |
| Fermanian, J | 2 |
| Millet, V | 1 |
| Dufour, H | 1 |
| Ryan, ND | 2 |
| Varma, D | 1 |
| Odom, AM | 1 |
| Ter Braak, GI | 1 |
| Attar-Lévy, D | 1 |
| Martinot, JL | 1 |
| Blin, J | 1 |
| Dao-Castellana, MH | 1 |
| Crouzel, C | 1 |
| Mazoyer, B | 1 |
| Bourdel, MC | 1 |
| Syrota, A | 1 |
| Féline, A | 1 |
| Ràfols Crestani, A | 1 |
| García Vicente, JA | 1 |
| Benazzi, F | 1 |
| Ohmori, O | 1 |
| Shinkai, T | 1 |
| Boyer, P | 1 |
| Gorman, JM | 1 |
| Kugaya, A | 1 |
| Akechi, T | 1 |
| Nakano, T | 1 |
| Okamura, H | 1 |
| Shima, Y | 1 |
| Uchitomi, Y | 1 |
| Alvarez, JC | 1 |
| Gluck, N | 1 |
| Arnulf, I | 1 |
| Quintin, P | 1 |
| Pecquery, R | 1 |
| Launay, JM | 1 |
| Perez-Diaz, F | 1 |
| Nierenberg, AA | 1 |
| Wright, EC | 1 |
| Ninan, PT | 1 |
| Leroi, AM | 1 |
| Lalaude, O | 1 |
| Antonietti, M | 1 |
| Touchais, JY | 1 |
| Ducrotte, P | 1 |
| Menard, JF | 1 |
| Denis, P | 1 |
| Gómez Gómez, JM | 1 |
| Teixidó Perramón, C | 1 |
| Samuelian, JC | 1 |
| Hackett, D | 1 |
| Lépine, JP | 1 |
| Goger, J | 1 |
| Blashko, C | 1 |
| Probst, C | 1 |
| Moles, MF | 1 |
| Kosolowski, J | 1 |
| Scharfetter, B | 1 |
| Lane, RM | 1 |
| Ueda, N | 1 |
| Eto, S | 1 |
| Nakamura, J | 1 |
| Manganotti, P | 1 |
| Bortolomasi, M | 1 |
| Zanette, G | 1 |
| Pawelzik, T | 1 |
| Giacopuzzi, M | 1 |
| Fiaschi, A | 1 |
| Hain, C | 1 |
| Yokono, A | 1 |
| Morita, S | 1 |
| Someya, T | 1 |
| Hirokane, G | 1 |
| Okawa, M | 1 |
| Barańczyk-Kuźma, A | 1 |
| Sawicki, J | 1 |
| Kuźma, M | 1 |
| Jagiełło, J | 1 |
| Golden, RN | 2 |
| Ekstrom, D | 2 |
| Brown, TM | 1 |
| Ruegg, R | 1 |
| Evans, DL | 1 |
| Haggerty, JJ | 1 |
| Garbutt, JC | 1 |
| Pedersen, CA | 1 |
| Mason, GA | 1 |
| Browne, J | 1 |
| Förstl, H | 1 |
| Pohlmann-Eden, B | 1 |
| Rothenberger, A | 1 |
| Lichtenberg, P | 1 |
| Guelfi, JD | 2 |
| De la Fuente, JM | 1 |
| Mendlewicz, J | 1 |
| Vallejo, J | 1 |
| Olivares, J | 1 |
| Marcos, T | 1 |
| Bulbena, A | 1 |
| Menchón, JM | 1 |
| Boringa, JB | 1 |
| de Jong, GM | 1 |
| Touw, DJ | 1 |
| François, TH | 1 |
| Yagmur, MJ | 1 |
| Gropp, C | 1 |
| Newman, M | 1 |
| Diaz Ruiz, O | 1 |
| Fineberg, NA | 1 |
| Bullock, T | 1 |
| Montgomery, DB | 1 |
| Montgomery, SA | 1 |
| Fineyre, F | 1 |
| Goodman, WK | 1 |
| McDougle, CJ | 1 |
| Price, LH | 1 |
| Beersma, DG | 2 |
| Anderson, IM | 1 |
| Ware, CJ | 1 |
| da Roza Davis, JM | 1 |
| Cowen, PJ | 1 |
| Manfredi, R | 1 |
| Zhao, J | 1 |
| Hasama, N | 1 |
| Yamada, K | 1 |
| Ihara, J | 1 |
| Yanagisawa, T | 1 |
| Mårtensson, B | 2 |
| Wägner, A | 1 |
| Beck, O | 1 |
| Brodin, K | 1 |
| Montero, D | 1 |
| Dechant, KL | 1 |
| Clissold, SP | 1 |
| Steiner, B | 2 |
| Wolfersdorf, M | 3 |
| Keller, F | 1 |
| Straub, R | 1 |
| Hole, G | 3 |
| Bartfai, A | 1 |
| Gustavsson, P | 1 |
| Aizenberg, D | 2 |
| Zemishlany, Z | 1 |
| Hermesh, H | 1 |
| Karp, L | 1 |
| Weizman, A | 1 |
| Schimmell, MS | 1 |
| Katz, EZ | 1 |
| Shaag, Y | 1 |
| Pastuszak, A | 1 |
| Koren, G | 1 |
| Lemoine, P | 1 |
| Boulenger, JP | 1 |
| Caillard, V | 1 |
| Tanne, N | 1 |
| Bonnet, D | 1 |
| Nisijima, K | 1 |
| Hirayama, M | 1 |
| Vallada, HP | 1 |
| Gentil, V | 1 |
| Solyom, L | 1 |
| Solyom, C | 1 |
| Ledwidge, B | 1 |
| Nagano, K | 1 |
| Ikezaki, A | 2 |
| Tashiro, T | 2 |
| Rampello, L | 1 |
| Nicoletti, G | 1 |
| Raffaele, R | 1 |
| Anderson, J | 1 |
| Bille, A | 1 |
| Christensen, EM | 1 |
| Høyer, E | 1 |
| Jensen, H | 1 |
| Mejlhede, A | 1 |
| Langagergaard, A | 1 |
| MacCrimmon, DJ | 1 |
| Arató, M | 1 |
| Saubadu, S | 1 |
| Chen, CJ | 1 |
| Noguera, R | 1 |
| Altuna, R | 1 |
| Ayuso, JL | 1 |
| Casais, L | 1 |
| Udina, C | 3 |
| Jarrett, DB | 2 |
| Pollock, B | 1 |
| Naylor, MW | 1 |
| Grossman, M | 1 |
| Pakesch, G | 1 |
| Dossenbach, M | 1 |
| Bihari, K | 1 |
| Pato, MT | 1 |
| Hill, JL | 1 |
| McEachran, AB | 1 |
| Bjerrum, H | 1 |
| Bøjholm, S | 1 |
| Butler, B | 1 |
| Folker, H | 1 |
| Loldrup, D | 1 |
| Hsiao, JK | 1 |
| Lane, E | 1 |
| Rogers, S | 1 |
| Hicks, R | 1 |
| Potter, WZ | 1 |
| Mellerup, ET | 2 |
| Plenge, P | 2 |
| DeVeaugh-Geiss, J | 1 |
| Trimble, MR | 1 |
| Elsenga, S | 3 |
| Beersma, D | 1 |
| Tiller, JW | 1 |
| Funke, HJ | 1 |
| Moritz, E | 1 |
| Hellstern, K | 3 |
| Malanowski, H | 2 |
| Civeira, J | 1 |
| Cervera, S | 1 |
| Giner, J | 1 |
| Allen, SR | 1 |
| Wirz, R | 1 |
| Klar, K | 1 |
| Dierick, M | 1 |
| Cattiez, P | 1 |
| Franck, G | 1 |
| Burton, P | 1 |
| Defleur, J | 1 |
| Hermans, W | 1 |
| Roelandts, A | 1 |
| Wolfrum, C | 1 |
| Berger, M | 4 |
| D'haenen, H | 1 |
| De Weert, D | 1 |
| Feyaerts, M | 1 |
| Nielsen, NP | 1 |
| Cesana, B | 1 |
| Zizolfi, S | 1 |
| Ascalone, V | 1 |
| Priore, P | 1 |
| Price, J | 1 |
| Grunhaus, LJ | 1 |
| Chiu, S | 1 |
| McFarlane, AH | 1 |
| Dobson, N | 1 |
| Flament, MF | 1 |
| Koby, E | 1 |
| Berg, CJ | 1 |
| Zahn, T | 1 |
| Cox, C | 1 |
| Denckla, M | 1 |
| Lenane, M | 1 |
| Hartley, P | 1 |
| Neill, D | 3 |
| Hagler, M | 3 |
| Kors, D | 3 |
| Vogel, G | 3 |
| Hennessey, A | 1 |
| Riemann, D | 3 |
| Fava, M | 1 |
| Anderson, K | 1 |
| Rosenbaum, JF | 1 |
| Gehris, TL | 1 |
| Kathol, RG | 1 |
| Black, DW | 1 |
| Noyes, R | 1 |
| Goronzy, JJ | 1 |
| Weyand, CM | 1 |
| Garrone, G | 2 |
| Van Sweden, B | 1 |
| Gagiano, CA | 1 |
| Müller, PG | 1 |
| Fourie, J | 1 |
| Le Roux, JF | 1 |
| Guillibert, E | 1 |
| Pelicier, Y | 2 |
| Archambault, JC | 1 |
| Chabannes, JP | 1 |
| Clerc, G | 1 |
| Desvilles, M | 1 |
| Guibert, M | 1 |
| Pagot, R | 1 |
| Poisat, JL | 1 |
| Thobie, Y | 1 |
| Young, A | 1 |
| Kehoe, R | 1 |
| Schifano, F | 1 |
| Magni, G | 3 |
| Warneke, L | 1 |
| Morgado, A | 1 |
| Raoux, N | 1 |
| Smith, M | 1 |
| Nagano, H | 1 |
| Fukuzako, H | 1 |
| Hokazono, Y | 1 |
| Tominaga, H | 1 |
| Hirakawa, K | 1 |
| Matsumoto, K | 1 |
| Nathan, RS | 2 |
| Ginestet, D | 1 |
| Manna, V | 1 |
| Ropert, R | 1 |
| Gloger, S | 1 |
| Grunhaus, L | 1 |
| Gladic, D | 1 |
| O'Ryan, F | 1 |
| Cohen, L | 1 |
| Codner, S | 1 |
| Garreau, M | 1 |
| Orofiamma, B | 1 |
| Palminteri, R | 1 |
| Koczkas, C | 1 |
| Karlsson, A | 1 |
| Nagy, A | 1 |
| Ose, E | 1 |
| Pétursson, H | 1 |
| Ulverås, L | 1 |
| Wenedikter, O | 1 |
| Linder, J | 1 |
| Fyrö, B | 1 |
| Pettersson, U | 1 |
| Werner, S | 1 |
| Bouhuys, AL | 1 |
| Stiller, RL | 1 |
| Curtis, GC | 1 |
| Murray, JB | 1 |
| Steardo, L | 1 |
| Barone, P | 1 |
| Monteleone, P | 1 |
| Iovino, M | 1 |
| Cardone, G | 1 |
| Fuster, MJ | 1 |
| Casas, M | 2 |
| Lloyd, KG | 1 |
| Zivkovic, B | 1 |
| Sanger, D | 1 |
| Depoortere, H | 1 |
| Bartholini, G | 1 |
| Ramos-Brieva, JA | 1 |
| Eberhard, G | 1 |
| von Knorring, L | 1 |
| Nilsson, HL | 1 |
| Sundequist, U | 1 |
| Björling, G | 1 |
| Linder, H | 1 |
| Svärd, KO | 1 |
| Tysk, L | 1 |
| Wendt, G | 2 |
| Binz, U | 2 |
| Cournoyer, J | 1 |
| Cole, JO | 1 |
| Baumgartner, A | 1 |
| Gräf, KJ | 1 |
| Kürten, I | 1 |
| Feder, R | 1 |
| Eikmeier, G | 1 |
| Kuhlmann, R | 1 |
| Stieglitz, RD | 1 |
| Metzger, R | 1 |
| von Oefele, K | 1 |
| Grohmann, R | 1 |
| Hippius, H | 1 |
| Rüther, E | 1 |
| Pallanti, S | 1 |
| Lieberman, JA | 1 |
| Kane, JM | 1 |
| Reife, R | 1 |
| Haaber, A | 1 |
| Joyce, CR | 1 |
| Ngo Khac, T | 1 |
| Gilsdorf, U | 1 |
| Urbani, A | 1 |
| Silvestro, A | 1 |
| Grassetto, M | 1 |
| Zysset, T | 1 |
| Foa, EB | 1 |
| Steketee, G | 1 |
| Kozak, MJ | 1 |
| Dugger, D | 1 |
| Connelly, P | 1 |
| Naylor, GJ | 1 |
| Sarrias, MJ | 1 |
| Martínez, E | 1 |
| Gelpí, E | 1 |
| Hale, AS | 1 |
| Procter, AW | 1 |
| Bridges, PK | 1 |
| Riley, AJ | 1 |
| Riley, EJ | 1 |
| Shostak, M | 2 |
| Brandom, B | 1 |
| Lehmann, HJ | 1 |
| Buchholz, G | 1 |
| Höchli, D | 2 |
| Zulley, J | 2 |
| Myers, BA | 1 |
| Klerman, GL | 1 |
| Hartmann, E | 1 |
| Baruch, P | 1 |
| Wargny, E | 1 |
| Lamiable, D | 1 |
| Havet, JM | 1 |
| Denis, J | 1 |
| Millart, H | 1 |
| Choisy, H | 1 |
| Pascalis, G | 1 |
| Modai, I | 2 |
| Mavissakalian, M | 1 |
| Turner, SM | 1 |
| Michelson, L | 1 |
| Jacob, R | 1 |
| Geenen, V | 1 |
| Ansseau, M | 1 |
| von Frenckell, R | 1 |
| Smitz, S | 1 |
| Legros, JJ | 1 |
| Brambilla, F | 1 |
| Pugnetti, L | 1 |
| Scarone, S | 1 |
| Gambini, O | 1 |
| Maggioni, M | 1 |
| Nobile, P | 1 |
| Christensen, P | 1 |
| Thomsen, HY | 1 |
| Rinsky, H | 1 |
| Cygielman, G | 1 |
| Ovuga, E | 1 |
| Aapro, N | 1 |
| Garrone, GE | 1 |
| Scarzella, L | 1 |
| Scarzella, R | 1 |
| Mailland, F | 1 |
| Bergamasco, B | 1 |
| Debray, Q | 1 |
| Plaisant, O | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Motivational Interviewing to Reduce Substance Use Among Depression Patients[NCT02420561] | 307 participants (Actual) | Interventional | 2010-10-31 | Completed | |||
| Silymarin Treatment of Body Dysmorphic Disorder: A Double-Blind, Placebo-Controlled, Cross-Over Study[NCT02843451] | Phase 2 | 0 participants (Actual) | Interventional | 2016-10-31 | Withdrawn (stopped due to Focus on other studies) | ||
| Quetiapine Augmentation Versus Clomipramine Augmentation of Selective Serotonin Reuptake Inhibitors for Obsessive-compulsive Disorder Patients That do Not Respond to a SSRI Trial: a Randomized Open-trial.[NCT00564564] | Phase 4 | 21 participants (Actual) | Interventional | 2006-01-31 | Completed | ||
| Efficacy and Safety Analyses of Mirtazapine in the Treatment of Malignant Tumor Related Depression: A Phase II, Placebo-controlled, Randomized, Double-blinded Clinical Trial in Advanced Non-small Cell Lung Cancer Patients[NCT02650544] | Phase 2 | 236 participants (Anticipated) | Interventional | 2015-12-31 | Active, not recruiting | ||
| Study of Antidepressants in Parkinson's Disease[NCT00086190] | Phase 3 | 115 participants (Actual) | Interventional | 2005-06-30 | Completed | ||
| Depression - Can Vitamin D Alleviate Symptoms of Depression Not Cured by Antidepressants as Well as Alleviate Negative Skeletal Effects Caused by Antidepressants?[NCT01932931] | 71 participants (Actual) | Interventional | 2013-10-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Beck Depression Inventory II ranges from 0-63. Higher score indicates more severe depression. 0-13 minimal depression, 14-19 mild depression, 20-28 moderate depression, 29-63 severe depression. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in BDI-II score (Mean) |
|---|---|
| Paroxetine | -9.7 |
| Venlafaxine Extended Release | -9.6 |
| Placebo | -5.2 |
Brief Psychiatric Rating Scale. Maximum score 126. Higher score indicates greater psychiatric difficulties. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in BPRS score (Mean) |
|---|---|
| Paroxetine | -9.0 |
| Venlafaxine Extended Release | -9.8 |
| Placebo | -4.4 |
Geriatric Depression Scale ranges from 0-30. Higher score indicates more severe depression. 0-9 normal, 10-19 mild depression, 20-30 severe depression. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in GDS score (Mean) |
|---|---|
| Paroxetine | -6.9 |
| Venlafaxine Extended Release | -6.9 |
| Placebo | -2.8 |
Change in Hamilton Rating Scale for Depression over 12 weeks. Hamilton Depression Rating Scale ranges from 0-50. Higher scores represent more significant depression. Mild depression ranges from 8-13, moderate depression from 14-18, severe 19-22 and very severe any score over 23. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in HAM-D score (Mean) |
|---|---|
| Paroxetine | -13.0 |
| Venlafaxine Extended Release | -11.0 |
| Placebo | -6.8 |
Montgomery-Asberg Depression Rating Scale ranges from 0-60. Higher score indicates more severe depression. 0-6 normal, 7-19 mild depression, 20-34 moderate depression, greater than 34 severe depression. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in MADRS score (Mean) |
|---|---|
| Paroxetine | -13.6 |
| Venlafaxine Extended Release | -10.9 |
| Placebo | -6.6 |
Parkinson's Disease Questionnaire (PDQ-39) - Emotional Well-Being maximum score 24, minimum score of 0.Lower score indicates a better perceived health status. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in PDQ-39 Emotional score (Mean) |
|---|---|
| Paroxetine | -21.4 |
| Venlafaxine Extended Release | -20.7 |
| Placebo | -10.9 |
Parkinson's Disease Questionnaire (PDQ-39) Total. Range 0-100. Lower score indicates a better perceived health status. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in PDQ-39 score (Mean) |
|---|---|
| Paroxetine | -8.0 |
| Venlafaxine Extended Release | -8.4 |
| Placebo | -5.3 |
Pittsburgh Sleep Quality Index scores range from 0-21, with higher scores indicating severe sleep difficulties. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in PQSI score (Mean) |
|---|---|
| Paroxetine | -2.1 |
| Venlafaxine Extended Release | -2.6 |
| Placebo | -1.1 |
Short Form 36 Health Survey. Range 0-100. Higher score indicates a better perceived quality of life. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in SF-36 mental score (Mean) |
|---|---|
| Paroxetine | 11.4 |
| Venlafaxine Extended Release | 9.5 |
| Placebo | 4.8 |
Short Form 36 Health Survey - Mental Health subscale ranges from 0-100. Higher score indicates a better perceived quality of life. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in SF-36 Mental Health score (Mean) |
|---|---|
| Paroxetine | 16.7 |
| Venlafaxine Extended Release | 17.4 |
| Placebo | 9.7 |
Short Form 36 Health Survey - Emotional subscale ranges from 0-100. Higher score indicates a better perceived quality of life. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in SF-36 Role score (Mean) |
|---|---|
| Paroxetine | 39.5 |
| Venlafaxine Extended Release | 26.9 |
| Placebo | 12.7 |
Short Form 36 Health Survey - Vitality subscale ranges from 0-100. Higher score indicates a better perceived quality of life. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in SF-36 vitality score (Mean) |
|---|---|
| Paroxetine | 13.5 |
| Venlafaxine Extended Release | 9.1 |
| Placebo | 4.7 |
Snaith Clinical Anxiety Scale. Range 0-21. Higher scores indicate increased anxiety. Score greater than 8 indicates clinical anxiety. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in CAS score (Mean) |
|---|---|
| Paroxetine | -3.6 |
| Venlafaxine Extended Release | -3.2 |
| Placebo | -2.4 |
Unified Parkinson's Disease Rating Scale. Higher score indicates more severe Parkinson's disease symptoms. Total maximum = 176. Mental maximum = 52, Activities of Daily Living maximum = 52, Motor maximum = 72. Minimum = 0. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in UPDRS score (Mean) |
|---|---|
| Paroxetine | -8.7 |
| Venlafaxine Extended Release | -7.0 |
| Placebo | -4.3 |
Unified Parkinson's Disease Rating Scale - Bulbar maximum score 24, minimum score of 0. Higher score indicates more severe Parkinson's disease symptoms. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in UPDRS-Bulbar score (Mean) |
|---|---|
| Paroxetine | -1.4 |
| Venlafaxine Extended Release | -1.4 |
| Placebo | -0.5 |
Unified Parkinson's Disease Rating Scale - Motor has a maximum score of 72, minimum score of 0. Higher score indicates more severe Parkinson's disease symptoms. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in UPDRS-motor score (Mean) |
|---|---|
| Paroxetine | -4.3 |
| Venlafaxine Extended Release | -2.0 |
| Placebo | -1.0 |
Unified Parkinson's Disease Rating Scale - Tremor subscale ranges from 0-23. Higher score indicates more severe Parkinson's disease symptoms. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in UPDRS-tremor score (Mean) |
|---|---|
| Paroxetine | 0.4 |
| Venlafaxine Extended Release | 0.5 |
| Placebo | -0.6 |
26 reviews available for clomipramine and Depression, Endogenous
| Article | Year |
|---|---|
Serum clomipramine and desmethylclomipramine levels in a CYP2C19 and CYP2D6 intermediate metabolizer.
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Cytochrome P-450 CYP2C19; Cytochrome P-450 CY | 2017 |
[Therapeutic strategy for drug resistant depression].
Topics: Animals; Antidepressive Agents; Biogenic Monoamines; Bupropion; Clomipramine; Depressive Disorder; D | 2004 |
[Current treatment of depression].
Topics: Administration, Oral; Antidepressive Agents; Antipsychotic Agents; Clomipramine; Depression; Depress | 1983 |
Are there anticompulsive or antiphobic drugs? Review of the evidence.
Topics: Adult; Antidepressive Agents; Child; Clomipramine; Depressive Disorder; Female; Humans; Male; Middle | 1983 |
Combined use of tricyclic antidepressants and monoamine oxidase inhibitors.
Topics: Adult; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Clomipramine; Depressive Disorder | 1983 |
Tryptophan and tyrosine availability: relation to clinical response to antidepressive pharmacotherapy.
Topics: Amitriptyline; Antidepressive Agents; Clomipramine; Depressive Disorder; Humans; Imipramine; Lithium | 1984 |
Plasma level monitoring of antidepressants: theoretical basis and clinical application.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Genetic Variatio | 1984 |
Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness.
Topics: Aged; Amitriptyline; Clomipramine; Depressive Disorder; Drug Interactions; Fluoxetine; Humans; Rando | 1995 |
Polymorphism in the metabolism of drugs, including antidepressant drugs: comments on phenotyping.
Topics: Clomipramine; Cytochromes; Dealkylation; Depressive Disorder; Desipramine; Dextromethorphan; Drug In | 1994 |
Morbid jealousy as a variant of obsessive-compulsive disorder.
Topics: Anxiety Disorders; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive | 1997 |
Mirtazapine: clinical advantages in the treatment of depression.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Clomipramine | 1997 |
Antidepressants in the treatment of premenstrual dysphoric disorder.
Topics: Adult; Antidepressive Agents; Clinical Trials as Topic; Clomipramine; Cyclohexanols; Depressive Diso | 1997 |
Clinical application of time-dependent sensitization to antidepressant therapy.
Topics: Animals; Antidepressive Agents; Clomipramine; Depressive Disorder; Drug Administration Schedule; Ele | 1998 |
Child and adolescent mood disorders--experience with serotonin-based therapies.
Topics: Adolescent; Adult; Child; Clomipramine; Depressive Disorder; Humans; Selective Serotonin Reuptake In | 1998 |
Mirtazapine: clinical overview.
Topics: Adrenergic alpha-Antagonists; Aged; Antidepressive Agents, Tricyclic; Clomipramine; Controlled Clini | 1999 |
Evolution of remission as the new standard in the treatment of depression.
Topics: Antidepressive Agents; Clinical Trials as Topic; Clomipramine; Cyclohexanols; Depressive Disorder; F | 1999 |
The functional anatomy, neurochemistry, and pharmacology of anxiety.
Topics: Adrenergic Uptake Inhibitors; Amygdala; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Clomipram | 1999 |
Serotonin reuptake inhibitors are the treatment of choice in obsessive compulsive disorder.
Topics: 1-Naphthylamine; Behavior Therapy; Clomipramine; Combined Modality Therapy; Depressive Disorder; Flu | 1992 |
Pharmacotherapy of obsessive compulsive disorder.
Topics: 1-Naphthylamine; Antidepressive Agents; Clomipramine; Depressive Disorder; Fluoxetine; Fluvoxamine; | 1992 |
Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.
Topics: Amitriptyline; Animals; Antidepressive Agents; Clomipramine; Depressive Disorder; Drug Evaluation; D | 1991 |
Worldwide use of clomipramine.
Topics: Anxiety Disorders; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind Method; | 1990 |
Tryptophan to competing amino acids ratio in depressive disorder: relation to efficacy of antidepressive treatments.
Topics: Amino Acids; Amitriptyline; Antidepressive Agents; Brain; Brain Chemistry; Clomipramine; Depressive | 1985 |
Successful treatment of obsessive-compulsive disorders.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Behavior Therapy; Clomipramine; Depressive Disorder; Ele | 1986 |
Neuromuscular effects of monoamine oxidase inhibitors.
Topics: 5-Hydroxytryptophan; Adult; Animals; Clomipramine; Clorgyline; Depressive Disorder; Female; Humans; | 1986 |
Clomipramine: an antiobsessive drug.
Topics: Anxiety; Behavior Therapy; Clinical Trials as Topic; Clomipramine; Compulsive Behavior; Depressive D | 1986 |
Obsessive-compulsive disorder.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Behavior Therapy; Clinical Trials as Topic; Clo | 1985 |
133 trials available for clomipramine and Depression, Endogenous
| Article | Year |
|---|---|
Is it possible to evaluate true prophylactic efficacy of antidepressants in severely ill patients with recurrent depression? Lessons from a placebo-controlled trial. The fifth trial of the Danish University Antidepressant Group (DUAG-5).
Topics: Antidepressive Agents; Citalopram; Clomipramine; Denmark; Depressive Disorder; Double-Blind Method; | 2013 |
Paroxetine versus clomipramine in adolescents with severe major depression: a double-blind, randomized, multicenter trial.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Child; Clomipramine; Depressive Disorder; Doubl | 2003 |
Fluvoxamine as effective as clomipramine against symptoms of severe depression: results from a multicentre, double-blind study.
Topics: Adult; Antidepressive Agents; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; D | 2003 |
Age may affect response to antidepressants with serotonergic and noradrenergic actions.
Topics: Adolescent; Adult; Age Factors; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agent | 2003 |
Multicenter double-blind randomized parallel-group clinical trial of efficacy of the combination clomipramine (150 mg/day) plus lithium carbonate (750 mg/day) versus clomipramine (150 mg/day) plus placebo in the treatment of unipolar major depression.
Topics: Administration, Oral; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Clomipra | 2003 |
Are gender differences important for the clinical effects of antidepressants?
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Double-B | 2003 |
Nitric oxide involvement in depression during interferon-alpha therapy.
Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorde | 2003 |
Clomipramine, fluoxetine and CYP2D6 metabolic capacity in depressed patients.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; | 2004 |
Motor cortex excitability after vagus nerve stimulation in major depression.
Topics: Adult; Benzodiazepines; Citalopram; Clomipramine; Clozapine; Depressive Disorder; Doxepin; Drug Ther | 2007 |
Efficacy of desipramine in endogenomorphically depressed patients.
Topics: Adjustment Disorders; Adolescent; Adult; Clinical Trials as Topic; Clomipramine; Depressive Disorder | 1980 |
Fluvoxamine and chlorimipramine in endogenous depression.
Topics: Adolescent; Adult; Antidepressive Agents; Bipolar Disorder; Clomipramine; Depressive Disorder; Doubl | 1982 |
Double blind test with mianserin versus chlorimipramine.
Topics: Adolescent; Adult; beta-Endorphin; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Dibe | 1982 |
[Clinical experience with clomipramine (Hydiphen) and desipramine (Petytyl) by parenteral administration in the treatment of endogenous depression with signs of pharmacoresistance].
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Desipramine; D | 1983 |
Combined use of tricyclic antidepressants and monoamine oxidase inhibitors.
Topics: Adult; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Clomipramine; Depressive Disorder | 1983 |
[Delayed-action clomipramine tablets in 78 ambulatory depressive patients: a double-blind study].
Topics: Adult; Aged; Ambulatory Care; Clinical Trials as Topic; Clomipramine; Delayed-Action Preparations; D | 1983 |
[Controlled study on the possible benefits of combination therapy with chlorimipramine and haloperidol inpatients with endogenous depression].
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Drug Combinati | 1984 |
A comparison of clomipramine and doxepin in neurotic depression.
Topics: Adolescent; Adult; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind Method; | 1984 |
Beta-receptor stimulation in the treatment of depression.
Topics: Affective Disorders, Psychotic; Albuterol; Bipolar Disorder; Clinical Trials as Topic; Clomipramine; | 1984 |
Treatment of depression with L-5-hydroxytryptophan combined with chlorimipramine, a double-blind study.
Topics: 5-Hydroxytryptophan; Adult; Aged; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Doubl | 1983 |
A double-blind comparison of lofepramine and clomipramine in depressed outpatients.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Dibenzazepines | 1984 |
Moclobemide and clomipramine in the treatment of depression. A randomized clinical trial.
Topics: Adult; Aged; Benzamides; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Dizziness; Dou | 1984 |
A double-blind comparative study of the clinical efficacy of fluvoxamine and chlorimipramine.
Topics: Adult; Antidepressive Agents; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Bl | 1983 |
Clinical trials of fluvoxamine vs chlorimipramine with single and three times daily dosing.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bipolar Disorder; Clinical Trials as Topic; Clomipra | 1983 |
Assessment of symptom change from improvement curves on the Hamilton depression scale in trials with antidepressants.
Topics: Adult; Aged; Antidepressive Agents; Clomipramine; Depressive Disorder; Female; Humans; Imipramine; M | 1984 |
Fluvoxamine maleate, a serotonergic antidepressant; a comparison with chlorimipramine.
Topics: Antidepressive Agents; Bipolar Disorder; Clinical Trials as Topic; Clomipramine; Depressive Disorder | 1982 |
A double-blind multicentre trial comparing the efficacy and side-effects of mianserin and chlorimipramine in depressed in- and outpatients.
Topics: Adolescent; Adult; Aged; Body Weight; Clinical Trials as Topic; Clomipramine; Depressive Disorder; D | 1980 |
Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis.
Topics: Adult; Amitriptyline; Anxiety Disorders; Clinical Trials as Topic; Clomipramine; Depressive Disorder | 1981 |
Maintenance of therapeutic effects of total sleep deprivation by limitation of subsequent sleep. A pilot study.
Topics: Clinical Trials as Topic; Clomipramine; Depressive Disorder; Female; Humans; Male; Middle Aged; Pilo | 1981 |
[Analysis of controlled studies comparing mianserin and clomipramine (author's transl)].
Topics: Adult; Aged; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Dibenzazepines; Double-Bli | 1981 |
Clomipramine and exposure for chronic obsessive-compulsive rituals: III. Two year follow-up and further findings.
Topics: Anxiety; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind Method; Female; F | 1982 |
Early clinical double-blind study with S-adenosyl-L-methionine: a new potential antidepressant.
Topics: Adult; Antidepressive Agents; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Bl | 1982 |
Relationship between the plasma concentration of clomipramine and desmethylclomipramine in depressive patients and the clinical response.
Topics: Adult; Aged; Biotransformation; Clomipramine; Depressive Disorder; Female; Humans; Male; Middle Aged | 1982 |
Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial.
Topics: Adult; Clomipramine; Depressive Disorder; Female; Humans; Male; Middle Aged; Nortriptyline; Obsessiv | 1980 |
Clomipramine and doxepin in depressive neurosis. Plasma levels and therapeutic response.
Topics: Adult; Clomipramine; Depressive Disorder; Doxepin; Female; Humans; Male; Reaction Time; Tryptophan | 1980 |
Moclobemide versus clomipramine in depressed patients in general practice. A randomized, double-blind, parallel, multicenter study.
Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzamides; Clomipramine; Depr | 1995 |
Hypothalamic-pituitary-gonadal axis in depressed premenopausal women: elevated blood testosterone concentrations compared to normal controls.
Topics: Adult; Clomipramine; Depressive Disorder; Estradiol; Female; Gonadal Steroid Hormones; Humans; Hypot | 1995 |
[Cytochrome p450 IID6, its role in psychopharmacology].
Topics: Adolescent; Adult; Aged; Clomipramine; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Depr | 1995 |
Effect of pulse loading with clomipramine on EEG sleep.
Topics: Adult; Clinical Protocols; Clomipramine; Delta Rhythm; Depressive Disorder; Dose-Response Relationsh | 1994 |
Effects of exclusion criteria in depression treatment studies.
Topics: Adult; Clomipramine; Depressive Disorder; Desipramine; Double-Blind Method; Female; Humans; Male; Ps | 1994 |
Determination of appropriate clomipramine dosage among depressed African outpatients in Dar es Salaam, Tanzania.
Topics: Administration, Oral; Adult; Analysis of Variance; Black People; Clomipramine; Depressive Disorder; | 1994 |
Relationships of the Tridimensional Personality Questionnaire to mood and personality measures for depressed patients.
Topics: Adolescent; Adult; Affect; Bipolar Disorder; Clomipramine; Depressive Disorder; Desipramine; Female; | 1994 |
Predictors of treatment response in obsessive-compulsive disorder: multivariate analyses from a multicenter trial of clomipramine.
Topics: Adolescent; Adult; Age Factors; Clomipramine; Depressive Disorder; Female; Humans; Male; Middle Aged | 1994 |
Inert placebo versus active medication. Patient blindability in clinical pharmacological trials.
Topics: Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind Method; Humans; Obsessive- | 1994 |
Early response patterns associated with successful clomipramine treatment.
Topics: Adult; Clomipramine; Depressive Disorder; Double-Blind Method; Electroencephalography; Female; Human | 1993 |
Pharmacokinetic study of yohimbine and its pharmacodynamic effects on salivary secretion in patients treated with tricyclic antidepressants.
Topics: Administration, Oral; Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Clomipramine; Depressi | 1994 |
Temperament predicts clomipramine and desipramine response in major depression.
Topics: Adult; Clomipramine; Comorbidity; Depressive Disorder; Desipramine; Double-Blind Method; Female; Hum | 1994 |
Changes in the frequency distribution pattern of body weight in patients with major depression.
Topics: Adult; Antidepressive Agents, Tricyclic; Body Weight; Clomipramine; Depressive Disorder; Desipramine | 1993 |
Prospective evaluation of the serotonin syndrome in depressed inpatients treated with clomipramine.
Topics: Adult; Aged; Aged, 80 and over; Arousal; Brain; Clomipramine; Depressive Disorder; Female; Humans; M | 1993 |
Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group.
Topics: Adult; Aged; Benzamides; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Half-Life; | 1993 |
Noradrenergic and serotoninergic depression?
Topics: Adult; Aged; Brain; Clomipramine; Depressive Disorder; Dexamethasone; Humans; Hydrocortisone; Maprot | 1993 |
Plasma amino acid profiles in relation to clinical response to moclobemide in patients with major depression. Danish University Antidepressant Group.
Topics: Adult; Aged; Amino Acids; Benzamides; Clomipramine; Depressive Disorder; Double-Blind Method; Female | 1993 |
Prolactin response to fenfluramine and placebo challenge following maintenance pharmacotherapy withdrawal in remitted depressed patients.
Topics: Clomipramine; Depressive Disorder; Drug Therapy, Combination; Female; Fenfluramine; Follow-Up Studie | 1993 |
Mortality in major affective disorder: relationship to subtype of depression. The Danish University Antidepressant Group.
Topics: Adult; Aged; Citalopram; Clomipramine; Denmark; Depressive Disorder; Female; Follow-Up Studies; Huma | 1993 |
Electrocardiographic changes during desipramine and clomipramine treatment in children and adolescents.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Child; Clomipramine; Cross-Over Studies; Death, Sudden | 1995 |
Combination treatment with clomipramine and fluvoxamine: drug monitoring, safety, and tolerability data.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Dose-Response Rela | 1996 |
The effect of a history of conduct disorder in adult major depression.
Topics: Adolescent; Adult; Alcoholism; Antidepressive Agents, Tricyclic; Child; Child Behavior Disorders; Cl | 1996 |
Fluvoxamine and fluoxetine: interaction studies with amitriptyline, clomipramine and neuroleptics in phenotyped patients.
Topics: Adult; Amitriptyline; Antipsychotic Agents; Clomipramine; Depressive Disorder; Drug Interactions; Fe | 1995 |
Estimation of the time course of slow-wave sleep over the night in depressed patients: effects of clomipramine and clinical response.
Topics: Administration, Oral; Adult; Antidepressive Agents; Circadian Rhythm; Clomipramine; Depressive Disor | 1996 |
Screening and treating depressed patients. A comparison of two controlled citalopram trials across treatment settings: hospitalized patients vs. patients treated by their family doctors. Danish University Antidepressant Group.
Topics: Citalopram; Clomipramine; Depressive Disorder; Family Practice; Female; Humans; Imipramine; Male; Ob | 1996 |
Moclobemide versus clomipramine in nonmelancholic, nonpsychotic major depression. A Study group.
Topics: Adolescent; Adult; Aged; Benzamides; Clomipramine; Depressive Disorder; Double-Blind Method; Female; | 1995 |
A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Antidepressive Agents, Tricyclic; Clomipramine; | 1996 |
Initial increase of plasma serotonin: a biological predictor for the antidepressant response to clomipramine?
Topics: Administration, Oral; Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Biomarkers; Blood P | 1996 |
Intimate bonds in depression.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Desipramine; | 1996 |
Serotonin syndrome during clomipramine monotherapy: comparison of two diagnostic criteria.
Topics: Adult; Clomipramine; Depressive Disorder; Female; Humans; Male; Middle Aged; Psychoses, Substance-In | 1997 |
The Major Depression Rating Scale (MDS). Inter-rater reliability and validity across different settings in randomized moclobemide trials. Danish University Antidepressant Group.
Topics: Antidepressive Agents; Benzamides; Clomipramine; Depressive Disorder; Drug Therapy, Combination; Hum | 1997 |
A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Anxiety Disorders; Clomipramine; Comorbidity; Depress | 1997 |
Pulse intravenous clomipramine for depressed adolescents: double-blind, controlled trial.
Topics: Adolescent; Age Factors; Ambulatory Care; Clomipramine; Depressive Disorder; Double-Blind Method; Fe | 1997 |
Effects of clomipramine on plasma amino acids and serotonergic parameters in panic disorder and depression.
Topics: Adult; Amino Acids; Antidepressive Agents, Tricyclic; Blood Platelets; Clomipramine; Depressive Diso | 1997 |
Clomipramine augmentation in treatment-resistant depression.
Topics: Adult; Aged; Akathisia, Drug-Induced; Analysis of Variance; Antidepressive Agents, Tricyclic; Chi-Sq | 1997 |
Monitoring serum concentrations of clomipramine and metabolites: fluorescence polarization immunoassay versus high performance liquid chromatography.
Topics: Antidepressive Agents, Tricyclic; Chromatography, High Pressure Liquid; Clomipramine; Depressive Dis | 1997 |
Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Clomipramine; Cyclopropanes; Depressive Disorder; Do | 1997 |
A double-blind six months comparative study of milnacipran and clomipramine in major depressive disorder.
Topics: Adult; Aged; Antidepressive Agents; Clomipramine; Constipation; Cyclopropanes; Depressive Disorder; | 1997 |
A double-blind, comparative study of dothiepin and clomipramine in the treatment of major depressive illness.
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Dothiepin; Double-Blind | 1997 |
The effect of clinical outcome on platelet G proteins of major depressed patients.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Blood Platelets; | 1998 |
Dimensional assessment of onset of action of antidepressants: a comparative study of moclobemide vs. clomipramine in depressed patients with blunted affect and psychomotor retardation.
Topics: Adult; Affective Symptoms; Analysis of Variance; Antidepressive Agents; Antidepressive Agents, Tricy | 1998 |
Parenteral clomipramine challenge in depressed adolescents: mood and neuroendocrine response.
Topics: Adolescent; Affect; Clomipramine; Depressive Disorder; Female; Growth Hormone; Humans; Infusions, Pa | 1998 |
The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine.
Topics: Adult; Aged; Antidepressive Agents; Binding Sites; Brain; Clomipramine; Depressive Disorder; Female; | 1999 |
Combined treatment with venlafaxine and tricyclic antidepressants in depressed patients who had partial response to clomipramine or imipramine: initial findings.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clomipramine; Cyc | 2000 |
A randomized, double-blind, parallel-group comparison of venlafaxine and clomipramine in outpatients with major depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; | 1998 |
A double-blind study of the efficacy and safety of sertraline and clomipramine in outpatients with severe major depression.
Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disor | 2000 |
Intravenous clomipramine decreases excitability of human motor cortex. A study with paired magnetic stimulation.
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Depression, Chemical; Depressive Disorder; El | 2001 |
Platelet adenylate cyclase activity in depression and after clomipramine and lithium treatment: relation to serotonergic function.
Topics: Adenylyl Cyclases; Alprostadil; Blood Platelets; Cell Membrane; Clomipramine; Colforsin; Depressive | 1992 |
The efficacy of reversible monoamine oxidase inhibitors in depressive illness.
Topics: Antidepressive Agents, Tricyclic; Benzamides; Clomipramine; Depressive Disorder; Humans; Imipramine; | 1992 |
Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial.
Topics: Adult; Clomipramine; Depressive Disorder; Dexamethasone; Dose-Response Relationship, Drug; Double-Bl | 1992 |
Effect of clomipramine and lithium on fenfluramine-induced hormone release in major depression.
Topics: Adult; Bipolar Disorder; Clomipramine; Depressive Disorder; Double-Blind Method; Drug Therapy, Combi | 1992 |
Moclobemide versus clomipramine in endogenous depression. A double-blind randomised clinical trial.
Topics: Adult; Aged; Antidepressive Agents; Benzamides; Clomipramine; Depressive Disorder; Double-Blind Meth | 1992 |
[Psychopathologic and psychophysiologic follow-up of inpatient depressed patients with standardized treatment with clomipramine and oxaprotiline].
Topics: Adult; Antidepressive Agents; Arousal; Clomipramine; Depressive Disorder; Dose-Response Relationship | 1991 |
Compared efficacy of prazepam and clomipramine in major depression with anxiety: a multicenter controlled study.
Topics: Adolescent; Adult; Aged; Anxiety; Child; Clomipramine; Depressive Disorder; Double-Blind Method; Fem | 1991 |
Dopaminergic hypothesis for retarded depression: a symptom profile for predicting therapeutical responses.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Arousal; Brain; Clomipramine; Depres | 1991 |
Moclobemide in depression: a randomized, multicentre trial against isocarboxazide and clomipramine emphasizing atypical depression.
Topics: Adult; Aged; Antidepressive Agents; Benzamides; Clomipramine; Depressive Disorder; Double-Blind Meth | 1991 |
[Amoxapine and clomipramine. A controlled multicenter study in patients with major depression].
Topics: Adult; Amoxapine; Clomipramine; Demography; Depressive Disorder; Double-Blind Method; Drug Evaluatio | 1991 |
Fluoxetine vs. clomipramine in depressed patients: a controlled multicentre trial.
Topics: Adult; Aged; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Mal | 1991 |
[Treatment of drug-resistant depression by intravenous administration of antidepressants].
Topics: Administration, Oral; Anthracenes; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Dibe | 1990 |
Acute effect of intravenous clomipramine upon sleep-related hormone secretion in depressed outpatients and healthy control subjects.
Topics: Adult; Circadian Rhythm; Clomipramine; Depressive Disorder; Female; Growth Hormone; Humans; Hydrocor | 1991 |
[Efficacy and safety of fluoxetine versus clomipramine in ambulatory patients with a depressive syndrome in a clinical trial with private practitioners].
Topics: Adult; Aged; Clomipramine; Depressive Disorder; Double-Blind Method; Family Practice; Female; Fluoxe | 1991 |
Plasma ratio tryptophan/neutral amino acids in relation to clinical response to paroxetine and clomipramine in patients with major depression.
Topics: Adult; Aged; Amino Acids; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind | 1990 |
Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group.
Topics: Adult; Antidepressive Agents; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Humans | 1990 |
The antiobsessional effects of clomipramine do not require concomitant affective disorder.
Topics: Adult; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Multicenter Stu | 1990 |
Worldwide use of clomipramine.
Topics: Anxiety Disorders; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind Method; | 1990 |
Total and partial sleep deprivation in clomipramine-treated endogenous depressives.
Topics: Body Temperature Regulation; Clomipramine; Combined Modality Therapy; Depressive Disorder; Electroen | 1990 |
Antidepressants, alcohol and psychomotor performance.
Topics: Antidepressive Agents; Anxiety Disorders; Clomipramine; Depressive Disorder; Dose-Response Relations | 1990 |
Moclobemide versus clomipramine in the treatment of depression: a single-centre study, Federal Republic of Germany.
Topics: Antidepressive Agents; Benzamides; Clomipramine; Depressive Disorder; Double-Blind Method; Germany; | 1990 |
Moclobemide versus clomipramine in the treatment of depression: a multicentre trial in Spain.
Topics: Adult; Antidepressive Agents; Benzamides; Clomipramine; Depressive Disorder; Dose-Response Relations | 1990 |
Moclobemide versus clomipramine in the treatment of depression: a double-blind multicentre study in Belgium.
Topics: Antidepressive Agents; Belgium; Benzamides; Clomipramine; Depressive Disorder; Double-Blind Method; | 1990 |
Therapeutic effects of fengabine, a new GABAergic agent, in depressed outpatients: a double-blind study versus clomipramine.
Topics: Adult; Antidepressive Agents; Chlorophenols; Clomipramine; Depressive Disorder; Double-Blind Method; | 1990 |
Urinary free cortisol levels in obsessive-compulsive disorder.
Topics: Adult; Clomipramine; Depressive Disorder; Dexamethasone; Female; Humans; Hydrocortisone; Male; Middl | 1990 |
The therapeutic efficacy of paroxetine: (a) an open study in patients with major depression not responding to antidepressants; (b) a double-blind comparison with amitriptyline in depressed outpatients.
Topics: Aged; Antidepressive Agents; Clomipramine; Depressive Disorder; Double-Blind Method; Drug Administra | 1989 |
A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients.
Topics: Aged; Antidepressive Agents; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Humans; | 1989 |
Acute antidepressant effect following pulse loading with intravenous and oral clomipramine.
Topics: Administration, Oral; Adult; Biological Availability; Clinical Trials as Topic; Clomipramine; Depres | 1989 |
Fluoxetine in endogenous depression and melancholia versus clomipramine.
Topics: Adult; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Mid | 1989 |
Double-blind controlled study on the clinical efficacy and safety of fluoxetine vs clomipramine in the treatment of major depressive disorders.
Topics: Adult; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Flu | 1989 |
Fluoxetine versus clomipramine in major depressive disorders.
Topics: Adult; Chemical Phenomena; Chemistry; Clomipramine; Depressive Disorder; Double-Blind Method; Female | 1989 |
Panic attacks and agoraphobia: low dose clomipramine treatment.
Topics: Adolescent; Adult; Agoraphobia; Anxiety Disorders; Clinical Trials as Topic; Clomipramine; Depressiv | 1989 |
Fengabine, a new GABAmimetic agent in the treatment of depressive disorders: an overview of six double-blind studies versus tricyclics.
Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Tricyclic; Bipolar D | 1989 |
Moclobemide and clomipramine in endogenous depression. A randomized clinical trial.
Topics: Adult; Aged; Antidepressive Agents; Benzamides; Clinical Trials as Topic; Clomipramine; Depressive D | 1989 |
Acute antidepressant effect of lithium is associated with fluctuation of calcium and magnesium in plasma. A double-blind study on the antidepressant effect of lithium and clomipramine.
Topics: Adult; Calcium; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind Method; Fe | 1989 |
Clomipramine and EEG sleep in depression.
Topics: Administration, Oral; Adult; Clomipramine; Depressive Disorder; Double-Blind Method; Electroencephal | 1989 |
Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Danish University Antidepressant Group.
Topics: Adolescent; Adult; Antidepressive Agents; Citalopram; Clinical Trials as Topic; Clomipramine; Depres | 1986 |
Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology.
Topics: Adult; Brain; Clomipramine; Depressive Disorder; Desipramine; Diagnosis, Differential; Female; Human | 1987 |
Therapeutic effect of maprotiline and chlorimipramine: controlled study.
Topics: Adult; Anthracenes; Bipolar Disorder; Clinical Trials as Topic; Clomipramine; Depressive Disorder; F | 1988 |
A double-blind randomized study of clomipramine versus maprotiline in patients with idiopathic pain syndromes.
Topics: Adult; Aged; Anthracenes; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind | 1988 |
CGP 12.103 A versus clomipramine in the treatment of depressed inpatients--results of a double-blind study.
Topics: Anthracenes; Antidepressive Agents; Blood Pressure; Clinical Trials as Topic; Clomipramine; Depressi | 1988 |
Where are those new antidepressants we were promised?
Topics: Antidepressive Agents; Bupropion; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Human | 1988 |
Double-blind study of oxaprotiline versus clomipramine in the treatment of depressive inpatients.
Topics: Adult; Aged; Anthracenes; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind | 1987 |
Clomipramine: an antiobsessive drug.
Topics: Anxiety; Behavior Therapy; Clinical Trials as Topic; Clomipramine; Compulsive Behavior; Depressive D | 1986 |
Experiments on clinical observation and judgement in the assessment of depression: profiled videotapes and Judgement Analysis.
Topics: Adult; Citalopram; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind Method; | 1986 |
Comparison of oral and intravenous treatment of depressive states: preliminary results of a WHO collaborative study.
Topics: Administration, Oral; Anthracenes; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Huma | 1986 |
Effects of imipramine on depression and obsessive-compulsive symptoms.
Topics: Adolescent; Adult; Aged; Clomipramine; Depressive Disorder; Humans; Imipramine; Middle Aged; Obsessi | 1987 |
Biological predictors of success of antidepressant drug therapy.
Topics: Age Factors; Anthracenes; Circadian Rhythm; Clomipramine; Depressive Disorder; Drug Administration S | 1987 |
Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II.
Topics: Adult; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Hum | 1985 |
Obsessive-compulsive disorder.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Behavior Therapy; Clinical Trials as Topic; Clo | 1985 |
Orthostatic side effects of clomipramine and citalopram during treatment for depression.
Topics: Adult; Citalopram; Clomipramine; Depressive Disorder; Female; Humans; Hypotension, Orthostatic; Male | 1985 |
Amineptine in the management of the depressive syndromes.
Topics: Adult; Age Factors; Aged; Antidepressive Agents, Tricyclic; Bipolar Disorder; Clomipramine; Depressi | 1985 |
228 other studies available for clomipramine and Depression, Endogenous
| Article | Year |
|---|---|
Synergistic effects of
Topics: Animals; Clomipramine; Curcumin; Depression; Depressive Disorder; Disease Models, Animal; Glutamine; | 2022 |
Obsession of pregnancy: Does it exist?
Topics: Attitude to Health; Citalopram; Clomipramine; Clonazepam; Cognitive Behavioral Therapy; Depressive D | 2017 |
In the Mirror: Depression With Dysmorphia and Obsessive-Compulsive Disorder.
Topics: Adult; Body Dysmorphic Disorders; Clomipramine; Depressive Disorder; Face; Female; Humans; Obsessive | 2018 |
Involvement of the microglial NLRP3 inflammasome in the anti-inflammatory effect of the antidepressant clomipramine.
Topics: Animals; Anti-Inflammatory Agents; Antidepressive Agents; Clomipramine; Cytokines; Depression; Depre | 2019 |
Zinc improves clomipramine effects on depressive and locomotor behavior and reverses its oxidative stress in rats.
Topics: Animals; Antidepressive Agents; Clomipramine; Depression; Depressive Disorder; Disease Models, Anima | 2019 |
Diabetes mellitus associated with clomipramine treatment: a retrospective analysis.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; | 2014 |
Recurrent brief depressive disorder in Dhat syndrome: A biological or psychological phenomenon!
Topics: Adult; Clomipramine; Cognitive Behavioral Therapy; Depressive Disorder; Fluoxetine; Humans; Male; Ob | 2016 |
Effect of neonatal clomipramine in the pathogenesis of ligature-induced periodontitis in Lewis rats.
Topics: Alveolar Bone Loss; Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Behavior, Animal; C | 2009 |
Effects of postnatal isolation rearing and antidepressant treatment on the density of serotonergic and noradrenergic axons and depressive behavior in rats.
Topics: Age Factors; Aging; Animals; Animals, Newborn; Antidepressive Agents; Antidepressive Agents, Tricycl | 2009 |
Repeated anabolic androgenic steroid treatment causes antidepressant-reversible alterations of the hypothalamic-pituitary-adrenal axis, BDNF levels and behavior.
Topics: Anabolic Agents; Androgens; Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Brain; Brai | 2010 |
Gene expression patterns in a rodent model for depression.
Topics: Animals; Clomipramine; Depressive Disorder; Disease Models, Animal; Female; Gene Expression; Male; O | 2010 |
Prolactin and cortisol responses to acute intravenous clomipramine challenge in patients with mania, depression and healthy controls: evidence for reduced serotonergic responsivity.
Topics: Adult; Aged; Analysis of Variance; Bipolar Disorder; Brain; Clomipramine; Depressive Disorder; Femal | 2011 |
Clinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sample.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B; ATP B | 2011 |
Therapeutic drug monitoring of clomipramine and amitriptyline in a depressed patient with upper digestive tract resection.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Drug Monitoring; | 2011 |
Clomipramine concentration and withdrawal symptoms in 10 neonates.
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Female; Half-Life; Human | 2012 |
Sleep-related epilepsy in a Long-Evans hooded rat model of depression.
Topics: Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Dise | 2012 |
Sleep homeostasis and depression: studies with the rat clomipramine model of depression.
Topics: Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Behavior, Animal; Clomipramine; Depress | 2012 |
Metabonomics approach to assessing the modulatory effects of St John's wort, ginsenosides, and clomipramine in experimental depression.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Animals; Antidepressive Agents; Behavior, Animal; Body | 2012 |
The chronic psychosocial stress paradigm in male tree shrews: evaluation of a novel animal model for depressive disorders.
Topics: Animals; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Disease Models, Animal | 2002 |
Sleep-wake effects of yohimbine and atropine in rats with a clomipramine-based model of depression.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Aggression; Animals; Animals, Newborn; Antidepressive Agen | 2002 |
Role of Gi proteins in the antidepressant-like effect of amitriptyline and clomipramine.
Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Brain; Brain Chemistry; Clomipramine; Depr | 2002 |
Genetic susceptibility of mesocortical dopamine to stress determines liability to inhibition of mesoaccumbens dopamine and to behavioral 'despair' in a mouse model of depression.
Topics: Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Clomipramine; Depressive Disorder; Dise | 2002 |
Differential effects of the 5-HT2 receptor antagonist on the anti-immobility effects of noradrenaline and serotonin reuptake inhibitors in the forced swimming test.
Topics: Adrenergic Uptake Inhibitors; Animals; Brain; Clomipramine; Depressive Disorder; Dose-Response Relat | 2002 |
Alterations in voiding frequency and cystometry in the clomipramine induced model of endogenous depression and reversal with fluoxetine.
Topics: Animals; Antidepressive Agents, Second-Generation; Clomipramine; Depressive Disorder; Escape Reactio | 2003 |
[Olanzapine in therapy of a somatoform disorder].
Topics: Antipsychotic Agents; Benzodiazepines; Chest Pain; Clomipramine; Depressive Disorder; Dose-Response | 2003 |
Antidepressants blunt the effects of inescapable stress on male mating behaviour and decrease corticotropin-releasing hormone mRNA expression in the hypothalamic paraventricular nucleus of the Syrian hamster (Mesocricetus auratus).
Topics: Animals; Antidepressive Agents, Tricyclic; Avoidance Learning; Clomipramine; Corticotropin-Releasing | 2004 |
Two cases involving clomipramine intoxication.
Topics: Adult; Antidepressive Agents, Tricyclic; Biotransformation; Chromatography, Gas; Clomipramine; Depre | 2004 |
[Paroxetine versus clomipramine in female adolescents suffering from anorexia nervosa and depressive episode--a retrospective study on tolerability, reasons for discontinuing the antidepressive treatment and different outcome measurements].
Topics: Adolescent; Anorexia Nervosa; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricy | 2004 |
Antidepressant effects of nicotine and fluoxetine in an animal model of depression induced by neonatal treatment with clomipramine.
Topics: Animals; Animals, Newborn; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepr | 2005 |
Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
Topics: Affect; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Antipsychotic | 2007 |
A kinetic-pharmacodynamic model for clinical trial simulation of antidepressant action: application to clomipramine-lithium interaction.
Topics: Antidepressive Agents; Clomipramine; Data Interpretation, Statistical; Depressive Disorder; Double-B | 2007 |
Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST).
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tri | 2008 |
Neonatal clomipramine induced endogenous depression in rats is associated with learning impairment in adulthood.
Topics: Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Fema | 2008 |
Therapeutic drug monitoring of tricyclic antidepressants in everyday clinical practice.
Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Clomipramine; Depressive D | 2007 |
Lateral habenula lesions improve the behavioral response in depressed rats via increasing the serotonin level in dorsal raphe nucleus.
Topics: Animals; Antidepressive Agents; Chronic Disease; Clomipramine; Depressive Disorder; Disease Models, | 2008 |
[Efficacy and tolerability of clomipramine, pirlindole and escitalopram in the treatment of neurotic level depression].
Topics: Adolescent; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive A | 2008 |
Behavioral effects of saredutant, a tachykinin NK2 receptor antagonist, in experimental models of mood disorders under basal and stress-related conditions.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety; Behavior, Animal; Benzamide | 2008 |
Beta-adrenergic stimulation and antidepressant activity.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Antidepressive Agents; Behavior, Animal; Clomipramine; | 1981 |
[Management of treatment-resistant depression without ECT (author's transl)].
Topics: Antipsychotic Agents; Clomipramine; Depressive Disorder; Female; Humans; Male; Maprotiline; Nomifens | 1981 |
[Treatment of endogenous depressions with maprotiline, clomipramine, dibenzepine and pyrlindole (author's transl)].
Topics: Adult; Antidepressive Agents; Carbazoles; Clomipramine; Depressive Disorder; Dibenzazepines; Female; | 1981 |
[Treatment of therapy-refractory depressions].
Topics: Anthracenes; Antidepressive Agents; Antipsychotic Agents; Clomipramine; Depressive Disorder; Drug Th | 1982 |
Urinary excretion of 5-hydroxyindoleacetic acid--no relationship to the level in cerebrospinal fluid.
Topics: Clomipramine; Depressive Disorder; Humans; Hydroxyindoleacetic Acid; Suicide, Attempted | 1982 |
Relevance of plasma levels during clomipramine treatment of primary depression.
Topics: Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Humans; Kinetics | 1982 |
Distal colon motility as a predictor of antidepressant response to fenfluramine, imipramine and clomipramine.
Topics: Adolescent; Adult; Clomipramine; Colon; Depressive Disorder; Double-Blind Method; Female; Fenflurami | 1983 |
Classification of depression and response to antidepressive therapies.
Topics: Amitriptyline; Clomipramine; Combined Modality Therapy; Depressive Disorder; Electroconvulsive Thera | 1983 |
Plasma levels and clinical response during treatment with clomipramine.
Topics: Adult; Clomipramine; Depressive Disorder; Female; Humans; Male; Middle Aged; Time Factors | 1984 |
[Radioimmunoassay of clomipramine and amitriptyline. Monitoring plasma levels of clomipramine in endogenous depression].
Topics: Amitriptyline; Clomipramine; Depressive Disorder; Humans; Radioimmunoassay | 1983 |
The TSH-response to TRH: A possible predictor of outcome to antidepressant and neuroleptic treatment.
Topics: Adolescent; Adult; Aged; Clomipramine; Depressive Disorder; Female; Haloperidol; Humans; Middle Aged | 1983 |
TSH-response patterns to TRH stimulation may indicate therapeutic mechanisms of antidepressant and neuroleptic drugs.
Topics: Adult; Clomipramine; Depressive Disorder; Female; Haloperidol; Humans; Prognosis; Psychiatric Status | 1984 |
5-HT reuptake inhibitors plus tryptophan in endogenous depression.
Topics: Biogenic Amines; Brompheniramine; Clomipramine; Depressive Disorder; Double-Blind Method; Drug Thera | 1981 |
Relevance of tryptophan and tyrosine availability in endogenous and 'non-endogenous' depressives treated with imipramine or clomipramine.
Topics: Biological Availability; Clomipramine; Depression; Depressive Disorder; Humans; Imipramine; Time Fac | 1981 |
Effects of clomipramine infusion on sleep in depressed patients.
Topics: Adult; Bipolar Disorder; Clomipramine; Depressive Disorder; Electroencephalography; Female; Humans; | 1984 |
[When do I give which antidepressant in the individual case?].
Topics: Anthracenes; Antidepressive Agents; Clomipramine; Depressive Disorder; Humans; Maprotiline; Monoamin | 1984 |
Biological markers in obsessive-compulsive and affective disorders.
Topics: Blood Platelets; Clomipramine; Clonidine; Depressive Disorder; Dexamethasone; Electroencephalography | 1984 |
Serial application of clonidine tests during antidepressive treatment with chlorimipramine.
Topics: Adult; Clomipramine; Clonidine; Depressive Disorder; Drug Therapy, Combination; Female; Growth Hormo | 1984 |
Simultaneous measurement of various antidepressants in the plasma of depressed patients by high performance liquid chromatography.
Topics: Adult; Amitriptyline; Amoxapine; Antidepressive Agents; Chromatography, High Pressure Liquid; Clomip | 1984 |
Cardiac effects of clomipramine treatment. ECG and left ventricular systolic time intervals.
Topics: Aged; Arrhythmias, Cardiac; Blood Pressure; Cardiomyopathies; Clomipramine; Depressive Disorder; Ele | 1983 |
Effect of sleep deprivation as a predictor of treatment response to antidepressant medication.
Topics: Adult; Aged; Anthracenes; Clomipramine; Depressive Disorder; Female; Humans; Male; Maprotiline; Midd | 1983 |
Unusual side effects of clomipramine associated with yawning.
Topics: Adult; Clomipramine; Depressive Disorder; Female; Humans; Male; Orgasm; Respiration | 1983 |
[Activation motor response in depressive states. Changes in the Hoffmann reflex during psychomotor testing].
Topics: Adult; Bipolar Disorder; Clomipramine; Depressive Disorder; Heart Rate; Humans; Middle Aged; Reflex, | 1983 |
Clinical and biological parameters as predictors for antidepressant drug responses in depressed patients.
Topics: Adult; Aged; Anthracenes; Catechol O-Methyltransferase; Clomipramine; Depressive Disorder; Dopamine | 1983 |
[Report of experiences with high dosage Hydiphen infusion treatment of depressive syndromes].
Topics: Adult; Bipolar Disorder; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Female | 1984 |
Neonatal convulsions caused by withdrawal from maternal clomipramine.
Topics: Adult; Clomipramine; Depressive Disorder; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases | 1982 |
[Our first experience with the antidepressive Hydiphen (clomipramine)].
Topics: Clomipramine; Depressive Disorder; Female; Humans; Male; Middle Aged | 1983 |
Antidepressant drugs in the treatment of obsessive-compulsive disorders.
Topics: Clomipramine; Depressive Disorder; Humans; Obsessive-Compulsive Disorder; Social Adjustment | 1983 |
Monoamine oxidase activity in platelets before and after sleep deprivation as predictor for antidepressive drug response.
Topics: Antidepressive Agents; Blood Platelets; Clomipramine; Depressive Disorder; Female; Humans; Kinetics; | 1983 |
Double-blind trial with oral versus intravenous clomipramine in primary depression.
Topics: Administration, Oral; Clomipramine; Depressive Disorder; Double-Blind Method; Humans; Injections, In | 1983 |
[Plasma levels of desmethylclomipramine and clomipramine at steady-state in the morning. Correlative analysis and prediction of theoretical blood clomipramine].
Topics: Adult; Aged; Circadian Rhythm; Clomipramine; Depressive Disorder; Female; Humans; Hydrocortisone; Ma | 1983 |
[Comparison of the onset of the therapeutic effect of clomipramine and desipramine after oral and intravenous administration in patients with endogenous depression].
Topics: Administration, Oral; Clomipramine; Depressive Disorder; Desipramine; Humans; Infusions, Parenteral | 1983 |
Pituitary-adrenal disinhibition in depression: marker of a subtype with characteristic clinical features and response to treatment?
Topics: Adult; Amitriptyline; Clomipramine; Depressive Disorder; Desipramine; Dexamethasone; Female; Humans; | 1981 |
Pharmacokinetics of clomipramine in depressive patients.
Topics: Administration, Oral; Adult; Clomipramine; Depressive Disorder; Female; Humans; Injections, Intramus | 1981 |
Neonatal effects of maternal clomipramine treatment.
Topics: Acidosis, Respiratory; Clomipramine; Cyanosis; Depressive Disorder; Female; Humans; Infant, Newborn; | 1982 |
On the clinical response/plasma level relationship for clomipramine.
Topics: Clomipramine; Depressive Disorder; Humans | 1982 |
Sexual disorders in the course of clomipramine treatment: a report of three cases.
Topics: Bipolar Disorder; Clomipramine; Depressive Disorder; Erectile Dysfunction; Humans; Male; Middle Aged | 1982 |
Neuroendocrine mechanisms in the therapeutic effects of antidepressant drugs: the "thyroid-axis" hypothesis.
Topics: Antidepressive Agents; Clomipramine; Depressive Disorder; Female; Humans; Psychiatric Status Rating | 1982 |
Clinical experience with maprotilin and maprotilin/clomipramine infusions in resistant depression.
Topics: Administration, Oral; Adult; Anthracenes; Clomipramine; Depressive Disorder; Drug Therapy, Combinati | 1982 |
[Combined chlorimipramine and maprotiline therapy in therapy-resistant depressions].
Topics: Adult; Anthracenes; Bipolar Disorder; Clomipramine; Depressive Disorder; Drug Therapy, Combination; | 1982 |
[Plasma level monitoring of psychotropic drugs in children. II -- Antidepressants (author's transl)].
Topics: Adolescent; Antidepressive Agents; Child; Clomipramine; Depressive Disorder; Enuresis; Female; Human | 1982 |
[Treatment of therapy-resistant depressions. Results of combined infusion treatment].
Topics: Anthracenes; Clomipramine; Depressive Disorder; Female; Humans; Infusions, Parenteral; Male; Maproti | 1982 |
Phospholipid liposomes in depression: a double-blind study versus placebo.
Topics: Adult; Aged; Clomipramine; Depressive Disorder; Double-Blind Method; Drug Synergism; Female; Humans; | 1982 |
Sexual dysfunction and clomipramine.
Topics: Adult; Clomipramine; Depressive Disorder; Drug Administration Schedule; Ejaculation; Erectile Dysfun | 1982 |
[Effect of antidepressants on the secretion of pituitary hormones in healthy subjects, neurotic depressive patients and endogenous depressive patients (author's transl)].
Topics: Adult; Anthracenes; Clomipramine; Depressive Disorder; Desipramine; Female; Growth Hormone; Humans; | 1980 |
The dexamethasone suppression test in the identification subtypes of depression differentially responsive to antidepressants [proceedings].
Topics: Adult; Age Factors; Aged; Amitriptyline; Clomipramine; Depressive Disorder; Desipramine; Dexamethaso | 1981 |
[Clinical investigation comparing trazodone and clomipramine].
Topics: Clomipramine; Depressive Disorder; Humans; Piperazines; Trazodone | 1980 |
[The problem of side-effects: cardiotoxicity (author's transl)].
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Dibenzocyclohept | 1981 |
[Clomipramine and desmethylclomipramine: relationship between plasma levels and clinical effect (author's transl)].
Topics: Adjustment Disorders; Adult; Aged; Clomipramine; Depressive Disorder; Female; Humans; Kinetics; Male | 1981 |
Uptake of 5-hydroxytryptamine and dopamine into platelets from depressed patients and normal subjects--influence of clomipramine, desmethylclomipramine and maprotiline.
Topics: Adjustment Disorders; Adult; Aged; Antidepressive Agents, Tricyclic; Blood Platelets; Clomipramine; | 1980 |
The WHO Depression Scale. Relationship to the Newcastle Scales.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Female; Humans; Im | 1980 |
Extreme suicidality following serotonin syndrome.
Topics: Adolescent; Antidepressive Agents; Clomipramine; Depressive Disorder; Dothiepin; Drug Administration | 1995 |
[Personality disorders and obsessive-compulsive disorder: critical analysis of the literature data and our studies].
Topics: Clomipramine; Comorbidity; Depressive Disorder; Fluoxetine; Humans; Obsessive-Compulsive Disorder; P | 1995 |
Acute vs. chronic EEG effects in maprotiline- and in clomipramine-treated depressive inpatients and the prediction of therapeutic outcome.
Topics: Adult; Aged; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Electroencephalogr | 1994 |
Combined pharmacotherapy: an emerging trend in pediatric psychopharmacology.
Topics: Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Child Psychiatry; | 1995 |
Possible serotonin syndrome following the combined administration of clomipramine and alprazolam.
Topics: Aged; Alprazolam; Clomipramine; Depressive Disorder; Female; Humans; Serotonin; Syndrome | 1995 |
[A case of rare side effects of certain antidepressive drugs].
Topics: Adult; Antidepressive Agents; Clomipramine; Depressive Disorder; Diagnosis, Differential; Drug Thera | 1995 |
Three cases of alopecia areata induced by zotepine.
Topics: Adult; Alopecia; Alopecia Areata; Antipsychotic Agents; Autoimmune Diseases; Carbamazepine; Clomipra | 1993 |
Figure drawing and psychomotor retardation: preliminary report.
Topics: Adult; Amitriptyline; Antipsychotic Agents; Clomipramine; Depressive Disorder; Female; Humans; Male; | 1993 |
The effects of a 3-day increase of ambient temperature on body temperature and REM sleep in an animal model of depression.
Topics: Acclimatization; Animals; Animals, Newborn; Body Temperature Regulation; Circadian Rhythm; Clomipram | 1994 |
Clomipramine therapy in the geriatric hospital: experience with therapeutic drug monitoring.
Topics: Adult; Aged; Aged, 80 and over; Clomipramine; Comorbidity; Depressive Disorder; Drug Interactions; D | 1994 |
Determination of 5-hydroxytryptamine and tryptophan by liquid chromatography in whole blood. Its interest for the exploration of mental disorders.
Topics: Adult; Antidepressive Agents, Tricyclic; Benzamides; Chromatography, High Pressure Liquid; Clomipram | 1994 |
Clinical significance of plasma levels of clomipramine, its hydroxylated and desmethylated metabolites: prediction of clinical outcome in mood disorders using discriminant analysis of therapeutic drug monitoring data.
Topics: Adolescent; Adult; Aged; Biotransformation; Bipolar Disorder; Clomipramine; Depressive Disorder; Dru | 1993 |
Concurrent agranulocytosis and hepatitis secondary to clomipramine therapy.
Topics: Aged; Agranulocytosis; Chemical and Drug Induced Liver Injury; Clomipramine; Depressive Disorder; Hu | 1993 |
[Scurvy after a suicide attempt by starvation].
Topics: Adult; Ascorbic Acid; Clomipramine; Depressive Disorder; Erythrocyte Count; Erythrocyte Indices; Hem | 1994 |
Cytokine production in major depressed patients before and after clomipramine treatment.
Topics: Adult; Aged; Clomipramine; Depressive Disorder; Female; Humans; Interleukin-1; Interleukin-2; Interl | 1994 |
Serotonin syndrome during clomipramine and lithium treatment.
Topics: Clomipramine; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Humans; Lithium; Ma | 1993 |
The central nervous system serotonin syndrome.
Topics: Adult; Central Nervous System; Clomipramine; Depressive Disorder; Dextromethorphan; Drug Interaction | 1993 |
Comorbid anxious signs and symptoms in major depression: impact on functional work capacity and comparative treatment outcomes.
Topics: Absenteeism; Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Anxiety; Clomipramine; Comorbid | 1993 |
Plasma-free and sulfoconjugated MHPG in major depressive disorders: differences between responders to treatment and nonresponders.
Topics: Adolescent; Adult; Aged; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Female | 1993 |
Sexual dysfunction during antidepressant treatment.
Topics: Adult; Ambulatory Care; Antidepressive Agents; Anxiety Disorders; Clomipramine; Depressive Disorder; | 1993 |
Decreased raphe unit activity in a rat model of endogenous depression.
Topics: Animals; Clomipramine; Depressive Disorder; Disease Models, Animal; Electric Stimulation; Evoked Pot | 1993 |
Body dysmorphic disorder: 30 cases of imagined ugliness.
Topics: Adolescent; Adult; Age Factors; Aged; Agoraphobia; Anxiety Disorders; Body Image; Clomipramine; Delu | 1993 |
[Infusion therapy with antidepressants in patients with depression].
Topics: Adult; Aged; Aged, 80 and over; Clomipramine; Depressive Disorder; Female; Follow-Up Studies; Humans | 1993 |
[Panic attacks and panic disorders in the child].
Topics: Anxiety, Separation; Child; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Dru | 1993 |
The benefits of clomipramine-fluoxetine combination in obsessive compulsive disorder.
Topics: Adult; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combinatio | 1993 |
Clomipramine efficacy for Tourette syndrome and major depression: a case study.
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Female; Humans; Tourette | 1995 |
Quality of life in depressed patients: comparison of fluoxetine and major tricyclic antidepressants.
Topics: Adult; Amitriptyline; Analysis of Variance; Antidepressive Agents, Tricyclic; Clomipramine; Depressi | 1996 |
Pharmacokinetic fluvoxamine-clomipramine interaction with favorable therapeutic consequences in therapy-resistant depressive patient.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clomipramine; Combined M | 1996 |
Depression as a dynamical disease.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Arousal; Brain; C | 1996 |
Rapid synergistic effects of lithium and antidepressants.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Clomipramine; Depressive Dis | 1995 |
Metabolic interaction between fluoxetine and clomipramine: a case report.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; | 1996 |
Status epilepticus associated with the combination of valproic acid and clomipramine.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Female; | 1997 |
Syndrome of inappropriate antidiuretic hormone (SIADH) in an 80-year-old woman given clomipramine.
Topics: Aged; Aged, 80 and over; Clomipramine; Delirium; Depressive Disorder; Diagnosis, Differential; Dose- | 1997 |
Three years on clomipramine: before and after brain SPECT study.
Topics: Anger; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Brain; Clomi | 1997 |
Density of guanine nucleotide-binding proteins in platelets of patients with major depression: increased abundance of the G alpha i2 subunit and down-regulation by antidepressant drug treatment.
Topics: Adult; Antidepressive Agents; Blood Platelets; Citalopram; Clomipramine; Depressive Disorder; Dose-R | 1997 |
Olfactory reference syndrome responds to clomipramine but not fluoxetine: a case report.
Topics: Adult; Clomipramine; Comorbidity; Delusions; Depressive Disorder; Fluoxetine; Humans; Male; Obsessiv | 1997 |
[The management of Sandra G].
Topics: Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Diagnosis, Differential; Humans | 1997 |
Muscle dysmorphia.
Topics: Adult; Body Constitution; Clomipramine; Depressive Disorder; Exercise; Humans; Male; Psychiatric Sta | 1997 |
Serotonin syndrome--clomipramine too soon after moclobemide?
Topics: Adult; Benzamides; Central Nervous System Diseases; Clomipramine; Depressive Disorder; Drug Interact | 1997 |
When fluvoxamine treats only depression and clomipramine treats only obsessive-compulsive disorder--combine them?
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Attention Deficit | 1998 |
Ultrarapid metabolism of clomipramine in a therapy-resistant depressive patient, as confirmed by CYP2 D6 genotyping.
Topics: Antidepressive Agents, Tricyclic; Clomipramine; Cytochrome P-450 CYP2D6; Depressive Disorder; Genoty | 1998 |
Relationship between blood serotonergic variables, melancholic traits, and response to antidepressant treatments.
Topics: Adult; Antidepressive Agents; Blood Platelets; Clomipramine; Depressive Disorder; Depressive Disorde | 1998 |
Pulse clomipramine for depressed adolescents.
Topics: Adolescent; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Humans; Placebos; Randomize | 1998 |
[The hyperglycemic dehydration syndrome].
Topics: Adult; Antidepressive Agents; Benzodiazepines; Clomipramine; Dehydration; Depressive Disorder; Diabe | 1998 |
[Hematological changes and antidepressive treatment].
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Female; Humans; Leukopen | 1999 |
Fluoxetine for clomipramine withdrawal symptoms.
Topics: Adult; Clomipramine; Comorbidity; Depressive Disorder; Fluoxetine; Humans; Male; Panic Disorder; Sub | 1999 |
A puzzling case of seizures and visual hallucinations during clomipramine treatment with a high dose but causing a low serum concentration.
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Hallucinations; Humans; | 1999 |
[Proofs of efficacy].
Topics: Antidepressive Agents, Tricyclic; Clomipramine; Cyclohexanols; Depressive Disorder; Dose-Response Re | 1999 |
Successful antidepressant treatment for five terminally ill cancer patients with major depression, suicidal ideation and a desire for death.
Topics: Affect; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Attitude to Death; Clomipramine; Cogn | 1999 |
Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Blood Platelets; | 1999 |
Prolonged stationary colonic motility recording in seven patients with severe constipation secondary to antidepressants.
Topics: Adult; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Cathartics; Cholinergic Antagonists; | 2000 |
Delirious episodes induced by intravenous administration of clomipramine associated with an acute increase in its plasma concentrations.
Topics: Aged; Clomipramine; Delirium; Depressive Disorder; Female; Humans; Injections, Intravenous; Middle A | 2000 |
Lithium therapy for corticosteroid-induced mood disorder.
Topics: Acute Disease; Adrenal Cortex Hormones; Antidepressive Agents, Tricyclic; Clomipramine; Comorbidity; | 2001 |
[Chronic discomfort with dentures - successful treatment with clomipramine].
Topics: Aged; Antidepressive Agents, Tricyclic; Clomipramine; Dental Restoration Failure; Dentures; Depressi | 2001 |
The effect of CYP2C19 and CYP2D6 genotypes on the metabolism of clomipramine in Japanese psychiatric patients.
Topics: Adolescent; Adult; Age Factors; Aged; Alleles; Antidepressive Agents, Tricyclic; Aryl Hydrocarbon Hy | 2001 |
[Tricyclic antidepressants as inhibitors of brain glutathione-S-transferase].
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Autopsy; Binding Sites; Brain; Clomipramine; Depres | 2001 |
Neuroendocrine effects of intravenous clomipramine in depressed patients and healthy subjects.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Clomipramine; Depressive Disorder; Female; Hospitali | 1992 |
[Changes in somatosensory evoked potentials in pharmacogenic myoclonia].
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Clomipramine; Depressive Disor | 1992 |
Carbamazepine addition in tricyclic antidepressant-resistant unipolar depression.
Topics: Aged; Anxiety Disorders; Carbamazepine; Clomipramine; Depressive Disorder; Dose-Response Relationshi | 1992 |
[Neonatal withdrawal symptoms following the use of clomipramine during pregnancy].
Topics: Adult; Clomipramine; Clonazepam; Depressive Disorder; Female; Humans; Infant, Newborn; Male; Neonata | 1992 |
Tricyclic antidepressant plasma levels after fluoxetine addition.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Dos | 1992 |
Clomipramine plasma levels among depressed outpatients in Benin, west Africa: drug compliance and comparison with Caucasian patients.
Topics: Ambulatory Care; Benin; Black People; Clomipramine; Depressive Disorder; Humans; Patient Compliance; | 1992 |
Neonatal treatment with clomipramine increased immobility in the forced swim test: an attribute of animal models of depression.
Topics: Animals; Animals, Newborn; Clomipramine; Defecation; Depressive Disorder; Disease Models, Animal; Ma | 1992 |
The serotonin syndrome.
Topics: Adult; Clomipramine; Depressive Disorder; Humans; Male; Myoclonus; Serotonin; Syndrome | 1992 |
Can non-REM sleep be depressogenic?
Topics: Antidepressive Agents, Tricyclic; Benzodiazepines; Clomipramine; Depressive Disorder; Electroencepha | 1992 |
Decreased 5-HT-mediated prolactin release in major depression.
Topics: Adult; Brain; Clomipramine; Depressive Disorder; Female; Humans; Infusions, Intravenous; Male; Perso | 1992 |
[A control study of intravenous versus oral clomipramine in major depression].
Topics: Administration, Oral; Adolescent; Adult; Clomipramine; Depressive Disorder; Female; Humans; Injectio | 1992 |
Circadian temperature and sleep-wake rhythms in depression.
Topics: Adult; Body Temperature Regulation; Circadian Rhythm; Clomipramine; Depressive Disorder; Female; Hum | 1992 |
Effects of clomipramine treatment on cerebrospinal fluid monoamine metabolites and platelet 3H-imipramine binding and serotonin uptake and concentration in major depressive disorder.
Topics: Adult; Blood Platelets; Carrier Proteins; Clomipramine; Depressive Disorder; Female; Homovanillic Ac | 1991 |
Memory effects of clomipramine treatment: relationship to CSF monoamine metabolites and drug concentrations in plasma.
Topics: Adult; Aged; Attention; Brain; Clomipramine; Depressive Disorder; Female; Homovanillic Acid; Humans; | 1991 |
Painful ejaculation associated with antidepressants in four patients.
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Ejaculation; Humans; Imi | 1991 |
Toxic neonatal effects following maternal clomipramine therapy.
Topics: Adult; Akathisia, Drug-Induced; Animals; Bottle Feeding; Breast Feeding; Clomipramine; Depressive Di | 1991 |
[ICU syndrome].
Topics: Aged; Anxiety; Benzodiazepines; Clomipramine; Critical Care; Delirium; Depressive Disorder; Female; | 1991 |
Musical hallucinations triggered by clomipramine?
Topics: Aged; Agoraphobia; Clomipramine; Depressive Disorder; Female; Hallucinations; Humans; Music | 1991 |
Fluoxetine treatment of obsessive-compulsive disorder.
Topics: Adult; Arousal; Clomipramine; Combined Modality Therapy; Depressive Disorder; Drive; Female; Fluoxet | 1991 |
Prediction of efficacy of antidepressant by 1-week test therapy in depression.
Topics: Adolescent; Adult; Bipolar Disorder; Clomipramine; Depressive Disorder; Dexamethasone; Dose-Response | 1991 |
Interhemispheric serotonergic asymmetry reflected in topographic pharmaco-EEG.
Topics: Brain Mapping; Cerebral Cortex; Clomipramine; Depressive Disorder; Dominance, Cerebral; Electroencep | 1991 |
The obsessive quality and clomipramine treatment in PTSD.
Topics: Clomipramine; Depressive Disorder; Hospitalization; Humans; Life Change Events; Psychiatric Status R | 1991 |
Trichotillomania and depression.
Topics: Adolescent; Clomipramine; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans | 1991 |
Neurologic soft signs in obsessive-compulsive disorder.
Topics: Adult; Anxiety Disorders; Central Nervous System Diseases; Clomipramine; Clonidine; Depressive Disor | 1991 |
Immediate effects of intravenous clomipramine on sleep and sleep-related secretion in depressed patients.
Topics: Adult; Arousal; Clomipramine; Delta Rhythm; Depressive Disorder; Electroencephalography; Female; Gro | 1991 |
Abnormal neuroendocrine responsivity to acute i.v. clomipramine challenge in depressed patients.
Topics: Adrenocorticotropic Hormone; Adult; Brain; Clomipramine; Depressive Disorder; Female; Growth Hormone | 1990 |
Why some depressed patients may have low platelet 3H-imipramine binding.
Topics: Antidepressive Agents; Blood Platelets; Carrier Proteins; Cell Membrane; Clomipramine; Depressive Di | 1990 |
Predictive value of two endogenicity measures.
Topics: Adult; Aged; Antidepressive Agents; Clomipramine; Depressive Disorder; Female; Hostility; Humans; Ma | 1990 |
Treatment of clomipramine-induced anorgasmia with yohimbine: a case report.
Topics: Adult; Clomipramine; Depressive Disorder; Humans; Male; Obsessive-Compulsive Disorder; Orgasm; Place | 1990 |
The treatment of monodelusional psychosis associated with depression.
Topics: Clomipramine; Delusions; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combin | 1990 |
Childhood obsessive-compulsive disorder: a prospective follow-up study.
Topics: Adolescent; Adult; Anxiety Disorders; Child; Clomipramine; Depressive Disorder; Dexamethasone; Femal | 1990 |
Procedure- and age-dependent hyperactivity in a new animal model of endogenous depression.
Topics: Aging; Animals; Antidepressive Agents; Clomipramine; Depressive Disorder; Disease Models, Animal; Hy | 1990 |
Diminished sexual activity in a new animal model of endogenous depression.
Topics: Animals; Clomipramine; Depressive Disorder; Disease Models, Animal; Rats; Rats, Inbred Strains; Sexu | 1990 |
REM sleep abnormalities in a new animal model of endogenous depression.
Topics: Animals; Clomipramine; Depressive Disorder; Disease Models, Animal; Male; Rats; Rats, Inbred Strains | 1990 |
The effects of total sleep deprivation and subsequent treatment with clomipramine on depressive symptoms and sleep electroencephalography in patients with a major depressive disorder.
Topics: Adolescent; Adult; Clomipramine; Depressive Disorder; Electroencephalography; Female; Humans; Male; | 1990 |
"Anger attacks": possible variants of panic and major depressive disorders.
Topics: Adult; Anger; Anxiety Disorders; Clomipramine; Clonazepam; Depressive Disorder; Desipramine; Diagnos | 1990 |
Eosinophilia, myopathy, and neuropathy in a patient with repeated use of L-tryptophan.
Topics: Adult; Clomipramine; Depressive Disorder; Drug Therapy, Combination; Eosinophilia; Female; Humans; L | 1990 |
Clomipramine metabolism. Model-based analysis of variability factors from drug monitoring data.
Topics: Adult; Aged; Aging; Biotransformation; Chromatography, High Pressure Liquid; Clomipramine; Dealkylat | 1990 |
Rebound antidepressant cardiac arrhythmia.
Topics: Cardiac Complexes, Premature; Clomipramine; Depressive Disorder; Electrocardiography; Female; Humans | 1988 |
Two cases of agranulocytosis on addition of a butyrophenone to a long-standing course of phenothiazine treatment.
Topics: Agranulocytosis; Antipsychotic Agents; Chlorpromazine; Clomipramine; Depressive Disorder; Dose-Respo | 1989 |
Panic attacks and major depression after discontinuation of long-term diazepam abuse.
Topics: Adult; Anxiety; Clomipramine; Depressive Disorder; Diazepam; Fear; Female; Humans; Panic; Substance | 1989 |
Intravenous chlorimipramine therapy in obsessive-compulsive disorder.
Topics: Administration, Oral; Adult; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Fo | 1989 |
Subjective bias in reports of poor work adjustment in depressed patients.
Topics: Adult; Clomipramine; Depressive Disorder; Female; Follow-Up Studies; Humans; Job Satisfaction; Male; | 1989 |
[Introduction of chronopharmacologic therapy of depressive disorders--a double-blind study using clomipramine].
Topics: Administration, Oral; Adolescent; Adult; Chronobiology Phenomena; Clomipramine; Depressive Disorder; | 1989 |
Jerk-locked averaging and somatosensory evoked potential in tricyclic-induced myoclonus: a case report.
Topics: Adult; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Electroencephalography; | 1989 |
Observed behavior as a predictor of the response to sleep deprivation in depressed patients.
Topics: Adult; Arousal; Attention; Clomipramine; Depressive Disorder; Female; Humans; Male; Middle Aged; Mot | 1989 |
High blood concentrations of imipramine or clomipramine and therapeutic failure: a case report study using drug monitoring data.
Topics: Aged; Clomipramine; Debrisoquin; Depressive Disorder; Female; Humans; Hydroxylation; Imipramine; Mid | 1989 |
Intravenous pulse loading of clomipramine in adolescents with depression.
Topics: Adolescent; Clomipramine; Depressive Disorder; Female; Humans; Male; Psychiatric Status Rating Scale | 1989 |
New findings in anxiety. A synthesis for clinical practice in 1985.
Topics: Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety; Anxiety Disorders; Behavior Therapy; | 1985 |
Is the dexamethasone suppression test predictive of response to specific antidepressant treatment in major depression?
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Bipolar Disorder; Clomipramine; Depressive Disord | 1987 |
Enhanced binding of [3H] (-) adrenaline to platelets of depressed patients with melancholia: effect of long-term clomipramine treatment.
Topics: Adult; Aged; Blood Platelets; Clomipramine; Depressive Disorder; Epinephrine; Female; Humans; Kineti | 1987 |
Fengabine, a novel antidepressant GABAergic agent. I. Activity in models for antidepressant drugs and psychopharmacological profile.
Topics: Animals; Antidepressive Agents; Avoidance Learning; Behavior, Animal; Bicuculline; Chlorophenols; Cl | 1987 |
[Rapid response of a disorder to the addition of lithium carbonate: panic resistant to tricyclic antidepressants].
Topics: Adult; Amitriptyline; Anxiety Disorders; Clomipramine; Depressive Disorder; Drug Therapy, Combinatio | 1986 |
Prolactin in patients with major depressive disorder and in healthy subjects. II. Longitudinal study of basal prolactin and post-TRH-stimulated prolactin levels.
Topics: Adult; Aged; Clomipramine; Depressive Disorder; Dexamethasone; Female; Humans; Hydrocortisone; Longi | 1988 |
Lithium augmentation of clomipramine.
Topics: Adult; Anxiety Disorders; Clomipramine; Depressive Disorder; Drug Synergism; Drug Therapy, Combinati | 1988 |
Body core temperature and depression during total sleep deprivation in depressives.
Topics: Body Temperature Regulation; Circadian Rhythm; Clomipramine; Combined Modality Therapy; Depressive D | 1988 |
Thrombosis of cerebral veins following intravenous application of clomipramine.
Topics: Cerebral Veins; Clomipramine; Depressive Disorder; Female; Humans; Infusions, Intravenous; Intracran | 1988 |
EEG characteristics of clinically defined on-drug-responders and non-responders--a comparison clomipramine vs. maprotiline.
Topics: Adult; Aged; Anthracenes; Clomipramine; Depressive Disorder; Electroencephalography; Female; Humans; | 1988 |
[Adverse drug reactions in combined treatment with tricyclic antidepressants and monoamine oxidase inhibitors].
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Dru | 1988 |
Clomipramine by different routes of administration: short- and long-term efficacy and predictors of clinical outcome.
Topics: Clomipramine; Depressive Disorder; Humans; Time Factors | 1987 |
Clomipramine-induced pancytopenia.
Topics: Clomipramine; Depressive Disorder; Humans; Male; Middle Aged; Pancytopenia | 1987 |
High plasma concentrations of desmethylclomipramine after chronic administration of clomipramine to a poor metabolizer.
Topics: Allopurinol; Clomipramine; Debrisoquin; Depressive Disorder; Female; Humans; Hydroxylation; Kinetics | 1987 |
Response to total sleep deprivation and clomipramine in endogenous depression.
Topics: Adult; Aged; Bipolar Disorder; Circadian Rhythm; Clomipramine; Combined Modality Therapy; Depressive | 1987 |
Clomipramine and flupenthixol--additive antidepressants?
Topics: Adult; Clomipramine; Depressive Disorder; Drug Therapy, Combination; Female; Flupenthixol; Humans; T | 1987 |
Decreased plasma serotonin in melancholic patients: a study with clomipramine.
Topics: Aged; Blood Platelets; Clomipramine; Depressive Disorder; Female; Humans; Male; Middle Aged; MMPI; P | 1987 |
Clomipramine, tryptophan and lithium in combination for resistant endogenous depression: seven case studies.
Topics: Adult; Antidepressive Agents, Tricyclic; Chronic Disease; Clomipramine; Depressive Disorder; Drug Re | 1987 |
Cyproheptadine and antidepressant-induced anorgasmia.
Topics: Adult; Clomipramine; Cyproheptadine; Depressive Disorder; Female; Humans; Imipramine; Sexual Dysfunc | 1986 |
Understanding the response lag to tricyclics. I. Application of pulse-loading regimens with intravenous clomipramine.
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Female; Humans; Injectio | 1986 |
The dexamethasone suppression test in depressive and schizophrenic patients under controlled treatment conditions.
Topics: Adult; Clomipramine; Depressive Disorder; Dexamethasone; Double-Blind Method; Endorphins; Female; Hu | 1986 |
[Atypical facial neuralgia or depressive facial pain. Diagnostic aspects of a well-demarcated form of masked depression].
Topics: Aged; Clomipramine; Depressive Disorder; Diagnosis, Differential; Drug Therapy, Combination; Facial | 1986 |
Initial REM sleep suppression by clomipramine: a prognostic tool for treatment response in patients with a major depressive disorder.
Topics: Adolescent; Adult; Bipolar Disorder; Clomipramine; Depressive Disorder; Female; Humans; Male; Middle | 1986 |
Chlorimipramine--but not imipramine--rapidly reduces [3H]imipramine binding in human platelet membranes.
Topics: Amitriptyline; Blood Platelets; Cell Membrane; Clomipramine; Depressive Disorder; Humans; Imipramine | 1986 |
Is there a relationship between response to total sleep deprivation and efficacy of clomipramine treatment in depressed patients?
Topics: Adolescent; Adult; Bipolar Disorder; Clomipramine; Depressive Disorder; Humans; Middle Aged; Prognos | 1986 |
Nocturnal cataclysms with myoclonus: a new side effect of clomipramine.
Topics: Clomipramine; Depressive Disorder; Female; Humans; Middle Aged; Myoclonus; Sleep Wake Disorders | 1986 |
Manic episode after propranolol withdrawal.
Topics: Bipolar Disorder; Clomipramine; Depressive Disorder; Female; Humans; Middle Aged; Propranolol; Subst | 1986 |
[Plasma levels of clomipramine and declomipramine in patients with depression: a study of its correlation with therapeutic efficacy].
Topics: Adolescent; Adult; Aged; Clomipramine; Depressive Disorder; Drug Therapy, Combination; Female; Human | 1986 |
Autoscopic and drug-induced perceptual disturbances. A case report.
Topics: Clomipramine; Depressive Disorder; Diagnosis, Differential; Female; Hallucinations; Humans; Middle A | 1985 |
Release of human neurophysin I during insulin-induced hypoglycemia in depressed patients is abolished after recovery with clomipramine treatment.
Topics: Blood Glucose; Clomipramine; Depressive Disorder; Female; Humans; Insulin; Middle Aged; Neurophysins | 1985 |
Abnormal anterior pituitary responsiveness to hypothalamic hormones in depression: neurophysiological correlates and psychopharmacological effects.
Topics: Adult; Aged; Bipolar Disorder; Clomipramine; Depressive Disorder; Desipramine; Female; Gonadotropin- | 1985 |
The DST as a predictor of acute response to treatment with ECT, chlorimipramine, amitriptyline, and phenelzine.
Topics: Amitriptyline; Clomipramine; Depressive Disorder; Dexamethasone; Electroconvulsive Therapy; Female; | 1986 |
Rapid achievement of antidepressant effect with intravenous chlorimipramine.
Topics: Adult; Clomipramine; Depressive Disorder; Female; Humans; Infusions, Parenteral; Male; Time Factors | 1985 |
Severe depression treatment: experience using maprotiline (Ludiomil) in combination with clomipramine (Anafranil).
Topics: Adolescent; Adult; Anthracenes; Clomipramine; Depressive Disorder; Drug Therapy, Combination; Humans | 1985 |
Treatment of major depressive disorder with melancholia.
Topics: Bromazepam; Clomipramine; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Fluraze | 1985 |
[Plasma levels of clomipramine and its metabolites in hospitalized depressed patients].
Topics: Adult; Aged; Clomipramine; Combined Modality Therapy; Depressive Disorder; Female; Hospitalization; | 1985 |